US20170189175A1 - Artificial, flexible valves and methods of fabricating and serially expanding the same - Google Patents
Artificial, flexible valves and methods of fabricating and serially expanding the same Download PDFInfo
- Publication number
- US20170189175A1 US20170189175A1 US15/308,667 US201515308667A US2017189175A1 US 20170189175 A1 US20170189175 A1 US 20170189175A1 US 201515308667 A US201515308667 A US 201515308667A US 2017189175 A1 US2017189175 A1 US 2017189175A1
- Authority
- US
- United States
- Prior art keywords
- leaflets
- stent
- valve
- canceled
- mandrel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
- A61F2/2433—Deployment by mechanical expansion using balloon catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2415—Manufacturing methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0008—Rounded shapes, e.g. with rounded corners elliptical or oval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0019—Angular shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/005—Rosette-shaped, e.g. star-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/001—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0029—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0036—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0037—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in height or in length
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0082—Additional features; Implant or prostheses properties not otherwise provided for specially designed for children, e.g. having means for adjusting to their growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
Definitions
- Valves exist in the body (e.g., in the heart and the systemic veins) to allow unidirectional blood flow.
- a variety of congenital conditions, infectious diseases (e.g., rheumatic heart disease), endocarditis, and age-related impairments (e.g., senile stenosis) can necessitate implantation of an artificial valve.
- an artificial, flexible valve including: a stent defining a wall and a plurality of leaflets extending from the wall of the stent.
- the plurality of leaflets form a plurality of coaptation regions between two adjacent leaflets.
- the coaptation regions include extensions along a z-axis and adapted and are configured to form a releasable, but substantially complete seal when the leaflets are in a closed position.
- the extensions can have a length along the z-axis between about 1 mm and about 10 mm.
- the extensions can have a curved profile.
- the curved profile can lie in an x-y plane.
- the curved profile can be a variance in extension length along the z-axis.
- the coaptation regions can have a substantially hyperbolic profile.
- Each of the plurality of leaflets can have a substantially elliptical leaflet-stent attachment line.
- the stent can be an expandable, cylindrical stent.
- the leaflets can be reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers.
- One or more selected from the group consisting of: coaptation regions and leaflet-stent attachment lines can be reinforced with one or more selected from the group consisting of: additional polymer thickness, reinforcing materials, and directional fibers.
- Adjacent leaflets can be coupled to a wide post of the stent.
- the wide post can include one or more windows.
- the wide post can have a width between about 0.5 mm and about 3 mm.
- the stent can include metal or plastic.
- the metal can be selected from the group consisting of: stainless steel, 316L stainless steel, cobalt-chromium alloys, and nickel-titanium alloys.
- the leaflets can be formed from a first polymer.
- the first polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
- the stent can be dip-coated in a second polymer.
- the second polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
- the leaflets can be coupled to the second polymer.
- the leaflets can be mechanically coupled to the second polymer.
- the leaflets can be chemically coupled to the second polymer.
- the leaflets can be coupled to the second polymer by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
- a leaflet-stent attachment line for each of the plurality of leaflets can substantially approximate a frame of the stent.
- the leaflet-stent attachment line can lie within about 3 mm of the frame of the stent.
- the stent can include one or more anchor points.
- the anchor points can contain a radio-opaque material.
- the valve can be adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary.
- the valve can be adapted and configured for insertion in a subject's veins in order to treat venous insufficiency.
- the valve can be adapted and configured for serial expansion as the subject ages.
- an artificial, flexible valve including: a stent defining a wall and a plurality of leaflets extending from the wall of the stent. Each of the plurality of leaflets terminates in a commissure line.
- the commissure lines deviate from a hyperbola formed in the x-y plane by at least one deviation selected from the group consisting of: a deviation in the z-direction and one or more curves relative to the hyperbola.
- the leaflets can further include extensions beyond the commissure lines along a z-axis.
- the extensions can have a length along the z-axis between about 1 mm and about 10 mm.
- the extensions can have a curved profile.
- the curved profile can lie in an x-y plane.
- the curved profile can be a variance in extension length along the z-axis.
- Each of the plurality of leaflets can have a substantially elliptical leaflet-stent attachment line.
- the stent can have an expandable, cylindrical stent.
- the leaflets can be reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers.
- One or more selected from the group consisting of: coaptation regions and leaflet-stent attachment lines can be reinforced with one or more selected from the group consisting of: additional polymer thickness, reinforcing materials, and directional fibers.
- Adjacent leaflets can be coupled to a wide post of the stent.
- the wide post can include one or more windows.
- the wide post can have a width between about 0.5 mm and about 3 mm.
- the stent can include metal or plastic.
- the metal can be selected from the group consisting of: stainless steel, 316L stainless steel, cobalt-chromium alloys, and nickel-titanium alloys.
- the leaflets can be formed from a first polymer.
- the first polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
- the stent can be dip-coated in a second polymer.
- the second polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
- the leaflets can be coupled to the second polymer.
- the leaflets can be mechanically coupled to the second polymer.
- the leaflets can be chemically coupled to the second polymer.
- the leaflets can be coupled to the second polymer by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
- a leaflet-stent attachment line for each of the plurality of leaflets can substantially approximate a frame of the stent.
- the leaflet-stent attachment line can lie within about 3 mm of the frame of the stent.
- the stent can include one or more anchor points.
- the anchor points can contain a radio-opaque material.
- the valve can be adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary.
- the valve can be adapted and configured for insertion in a subject's veins in order to treat venous insufficiency.
- the valve can be adapted and configured for serial expansion as the subject ages.
- an artificial, flexible valve including: an expandable, cylindrical stent defining a wall and a plurality of leaflets extending from the wall of the stent. Adjacent leaflets can be coupled to a relatively wide post of the stent.
- the leaflets can further include extensions beyond the commissure lines along a z-axis.
- the extensions can have a length along the z-axis between about 1 mm and about 10 mm.
- the extensions can have a curved profile.
- the curved profile can lie in an x-y plane.
- the curved profile can be a variance in extension length along the z-axis.
- the coaptation regions can have a substantially hyperbolic profile.
- Each of the plurality of leaflets can have a substantially elliptical leaflet-stent attachment line.
- the leaflets can be reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers.
- One or more selected from the group consisting of: coaptation regions and leaflet-stent attachment lines can be reinforced with one or more selected from the group consisting of: additional polymer thickness, reinforcing materials, and directional fibers.
- the relatively wide post can include one or more windows.
- the relatively wide post can have a width between about 0.5 mm and about 3 mm.
- the stent can include metal or plastic.
- the metal can be selected from the group consisting of: stainless steel, 316L stainless steel, cobalt-chromium alloys, and nickel-titanium alloys.
- the leaflets can be formed from a first polymer.
- the first polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
- the stent can be dip-coated in a second polymer.
- the second polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
- the leaflets can be coupled to the second polymer.
- the leaflets can be mechanically coupled to the second polymer.
- the leaflets can be chemically coupled to the second polymer.
- the leaflets can be coupled to the second polymer by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
- a leaflet-stent attachment line for each of the plurality of leaflets can substantially approximate a frame of the stent.
- the leaflet-stent attachment line can lie within about 3 mm of the frame of the stent.
- the stent can include one or more anchor points.
- the anchor points can contain a radio-opaque material.
- the valve can be adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary.
- the valve can be adapted and configured for insertion in a subject's veins in order to treat venous insufficiency.
- the valve can be adapted and configured for serial expansion as the subject ages.
- the valve may not contain any animal-derived materials.
- a mandrel including: a cylindrical profile and a plurality of recesses adapted and configured to define a plurality of leaflets forming a plurality of coaptation regions between two adjacent leaflets.
- the coaptation regions can include extensions along a z-axis and be adapted and configured to form a releasable, but substantially complete seal when the leaflets are in a closed position.
- the mandrel can include one more cutting guides located between the plurality of recesses.
- the mandrel can include one or more heating elements.
- a mandrel including: a cylindrical profile and a plurality of recesses adapted and configured to define a plurality of leaflets.
- Each of the plurality of leaflets terminate in a commissure line.
- the commissure lines deviate from a hyperbola formed in the x-y plane by at least one deviation selected from the group consisting of: a deviation in the z-direction and one or more curves relative to the hyperbola.
- the mandrel can include one more cutting guides located between the plurality of recesses.
- the mandrel can include one or more heating elements.
- Another aspect of the invention provides a method for fabricating an artificial, flexible valve.
- the method includes: dip coating a cylindrical mandrel having a plurality of recesses each approximating a profile of a leaflet and coupling the leaflets to an inner wall of a stent.
- the method can further include dip coating the stent prior to coupling the leaflets to the inner wall of the stent.
- the stent and the mandrel can have larger diameters than a target location for the valve.
- the method can further include separating adjacent leaflets from each other.
- FIGS. 1A and 1B provide perspective (in which fluid flows from the bottom of the stent toward the top of the stent) and top (in which fluid flows out of the page when the valve is open and flows down into the page to close the valve) views of a valve according to an embodiment of the invention
- FIG. 2 depicts a stent according to an embodiment of the invention
- FIGS. 3A-3F depict various stent geometries according to embodiments of the invention.
- FIG. 4 depicts various vertical post geometries according to embodiments of the invention.
- FIGS. 5A-5D depict the positioning of a leaflet joint adjacent to a window of a vertical post according to an embodiment of the invention
- FIG. 6 depicts a stent prior to expansion, dip coating, and leaflet installation according to an embodiment of the invention
- FIG. 7 depicts a stent including one or more anchor points according to an embodiment of the invention.
- FIG. 8 depicts the engagement of a stent with a holder for dipping and rotation according to an embodiment of the invention
- FIGS. 9A-9E depict a mandrel according to an embodiment of the invention.
- FIG. 9F depicts the positioning of a hyperbolic commissure line relative to defined asymptotes according to embodiments of the invention.
- FIG. 10A depicts a comparison of elliptical vs. parabolic geometries leaflet valley lines according to embodiments of the invention.
- FIGS. 10B and 10C depict a comparison of elliptical vs. parabolic leaflet stent attachment lines according to embodiments of the invention.
- FIGS. 11A-11D depict mandrels for forming coaptation regions of varying height according to embodiments of the invention.
- FIGS. 12A-12D depict mandrels for forming coaptation regions of varying radial length according to embodiments of the invention
- FIGS. 12E-12H depict mandrels for forming commissure lines having variable depths along the z-axis according to embodiments of the invention
- FIGS. 12I-12K depict mandrels for forming coaptation regions having curved profiles in an x-y plane, resulting in increased coaptation length, according to embodiments of the invention
- FIGS. 12L-12N depict mandrels for forming commissure lines having curved profiles in an x-y plane, resulting in increased coaptation length, according to embodiments of the invention
- FIG. 13A depicts a mandrel according to an embodiment of the invention
- FIGS. 13B and 13C depict the positioning of reinforcing zones on a mandrel according to an embodiment of the invention
- FIGS. 14A-14C depict various top profiles according to an embodiment of the invention.
- FIGS. 15A and 15B depict the fabrication of valves according to embodiments of the invention.
- FIG. 16 depict the fabrication of valves according to an embodiment of the invention.
- FIGS. 17A and 17B depict the compression of a valve after assembly in order to bring leaflets into contact with each other according to embodiments of the invention
- FIG. 17C is a high-speed photograph of a closed valve under pressure according to embodiments of the invention.
- FIG. 18 depicts a method of implanting a valve according to embodiments of the invention.
- FIG. 19 depicts a method of expanding an implanted valve according to embodiments of the invention.
- the term “about” is understood as within a range of normal tolerance in the art, for example within 2 standard deviations of the mean. “About” can be understood as within 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.05%, or 0.01% of the stated value. Unless otherwise clear from context, all numerical values provided herein are modified by the term about.
- Ranges provided herein are understood to be shorthand for all of the values within the range.
- a range of 1 to 50 is understood to include any number, combination of numbers, or sub-range from the group consisting 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 (as well as fractions thereof unless the context clearly dictates otherwise).
- aspects of the invention provide a novel platform that allows development of polymeric valves of any size and shape.
- aspects of the invention can be applied to valves designed for surgical implantation (e.g., through a sternotomy or thoracotomy) or valves designed for percutaneous, transcatheter implantation. Additionally, embodiments of the invention allow for possible percutaneous replacement of a dysfunctional valve, whether in adults or in small children. In addition, if implanted in a child, embodiments of the invention allow the valve to be serially expanded to accompany the child's growth.
- Heart valves are currently replaced using tissue valves (homograft or xenograft) or mechanical metal valves, each having their shortcomings. Homograft valves are in short supply, particularly in sizes suitable for use in children, and biologic tissue-based valves (whether bovine, porcine, or homograft) tend to induce an immunologic reaction which leads to failure of these valves. Mechanical valves generally require anticoagulation, and are almost never used in the pulmonary position due to an increased risk of thrombosis.
- aspects of the invention can be used for venous valve replacement in patients having venous disease such as chronic venous insufficiency (leading to leg swelling). Because the polymer leaflets can be made extremely thin, the valves can even open under extremely low venous pressure gradients.
- valve 100 provides an artificial, flexible valve 100 .
- the valve includes an expandable, cylindrical stent 102 defining a wall 104 .
- Valve 100 further includes a plurality of leaflets 106 a - 106 c .
- Wall 104 can be formed by dip coating stent 102 in a polymer as further described herein.
- Leaflets 106 can be coupled to wall 104 along seams 108 using a variety of approaches (e.g., glue) as discussed further herein.
- Stent 102 can include one or more vertical posts 110 , 112 , which can be relatively narrow posts 110 or relatively wide posts 112 .
- leaflet joints between adjacent leaflets 106 are positioned on or close to a vertical post 110 , 112 of the stent 102 .
- valve 100 will now be described in the context of its components and methods of fabrication.
- stent 102 can be a metallic stent having plurality of wires, strips, and the like 202 defining a plurality of cells 204 , 206 of various sizes.
- Stent 102 can be fabricated from a variety of malleable materials such as stainless steel, 316L stainless steel, cobalt-chromium alloys, nickel-titanium alloys (colloquially known as “nitinol”), and the like.
- Stent 102 can also be formed from various non-metallic materials such as plastics such as polyethylene, polyurethane, polytetrafluoroethylene (PTFE), silicone, poly(propylene) (PP), polyethylene terephthalate (PET), and the like.
- plastics such as polyethylene, polyurethane, polytetrafluoroethylene (PTFE), silicone, poly(propylene) (PP), polyethylene terephthalate (PET), and the like.
- Stent 102 can be completely enveloped by a polymer dip coating.
- Stent 102 and/or wall 104 can also be fabricated from a biocompatible material.
- the stent 102 can be manufactured by laser cutting or wire forming. To increase bonding strength between metal and polymer, roughness of stent surface can be controlled. Some or all open cells 204 , 206 of the stent can be covered as the bare 102 stent is dipped into the polymer solution.
- FIG. 6 depicts a stent 102 prior to expansion, dip coating, and leaflet installation.
- Stents 102 typically have a diameter of between about 2 mm and 6 mm prior to expansion and can be expanded to between about 5 mm and about 30 mm for implantation into a subject.
- the components of stent 102 can have a variety of dimensions that can be selected to achieve a desired flexibility, rigidity, resilience, and the like.
- the thickness and width of components of the stent 102 can be between about 0.1 mm and about 2 mm.
- stent 102 can include one or more vertical posts 110 a - 110 c to enhance bonding with leaflets 106 .
- Stent 102 can include a plurality of vertical posts 110 that can serve a variety of functions. Some vertical posts 110 can include additional structure and are referred to herein as wide posts 112 . Wide posts 112 are preferably located at leaflet joints where two leaflets 106 meet. For example, in a valve 100 having a three leaflets 106 , wide posts 112 can be positioned at 120° intervals within cylindrical stent 102 .
- Wide posts 112 provide mechanical support to leaflets and prevent or substantially limit inward deformation of wall 104 due to tensile forces applied to leaflets 106 transferred to wall 104 . Without being bound by theory, it is believed that the wide posts 112 provide increased strength and resiliency due to formation of polymer wall 104 through windows 206 and around wide posts 112 , thus providing cohesive holding of the polymer to itself around the stent 102 instead of relying solely on adhesive bonding of the polymer wall 104 to the stent 102 .
- window 208 can have a width of between about 0.5 mm and about 3 mm (e.g., about 1 mm) and a height of between about 1 mm and about 10 mm (e.g., about 5 mm).
- FIGS. 3A-3F A variety of additional wide post geometries are depicts in FIGS. 3A-3F .
- the wide posts have a solid architecture without any windows.
- the wide posts have a substantially rectangular architecture defining a single, long window as in FIGS. 1A, 1B, and 2 .
- the wide posts define a plurality of coaxial substantially rectangular windows.
- the wide posts define a plurality of coaxial, substantially parallel windows.
- FIG. 3E the wide posts define a plurality of coaxial, substantially rectangular windows in a 2 ⁇ 3 arrangement.
- the wide posts include a plurality of circular windows.
- any geometry can be utilized including windows having a profile approximating a triangle, a square, an n-gon (e.g., a hexagon, an octagon, and the like), and the like.
- FIGS. 5A-5D the positioning of a leaflet joint 502 (formed, e.g., on mandrel 900 as discussed herein) adjacent to window 206 of wide post 112 is depicted.
- the polymer dip-coated wall 104 is completely transparent for ease and clarity in viewing, but can be transparent, translucent, or opaque.
- FIG. 5B-5D further depict how a geometry of the stent 102 can be selected to substantially approximate the leaflet-stent attachment seam 108 discussed herein in order to provide added mechanical support and resiliency.
- stent 102 can include one or more anchor points 702 .
- Anchor points 702 advantageously facilitate holding, dipping, and rotation of the stent 102 during the dip coating process without interfering with the dip coating of the remainder of the stent architecture. Accordingly, the entire stent 102 can be dip coated in a single dipping, although multiple dippings can be utilized to control coating density, thickness, and the like.
- Anchor points 702 can also receive one or more radio-opaque materials such as platinum to aid in placement and visualization of the valve.
- stent 102 can be engaged with a holder 802 (e.g., by posts 804 ) for dipping and rotation.
- a holder 802 e.g., by posts 804
- the polymer e.g., polymer that is wet on the stent 102
- the stent can be positioned horizontally and rotated axially.
- Leaflets 106 can be formed using a variety of techniques including dip coating, 3D-printing (also known as additive manufacturing), molding, and the like.
- leaflets 106 can be fabricated by dip coating a mandrel 900 with a polymer.
- the mandrel 900 can be made with a solid such as a metal (e.g., stainless steel, titanium, aluminum, and the like), a plastic (e.g., polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroethylene, polyoxymethylene, and the like), and the like. Since the coated polymer leaflets 106 will be removed from the mandrel 900 after the polymer dries, roughness of mandrel surface can be controlled using known machining and other manufacturing techniques.
- the mandrel 900 can be made from a cylinder.
- the diameter of the mandrel 900 is a slightly (e.g., between about 0.05 and about 0.4 mm) smaller than inner diameter of stent 102 after expansion.
- the mandrel 900 for the leaflets 106 can have novel features, including edges representing the leaflet attachment points that are mathematically defined and leaflet tips that are extended in order to increase the coaptation length of the leaflets.
- the mandrel 900 can be dimensioned to produce leaflets 106 having different regional thickness and supplementary materials such as directional fibers or reinforcing particles inserted between layers or mixed into the polymer solution in order to increase durability. For example, polymer interaction with particles on the nanoscale or microscale can greatly improve the physical properties or tear resistance of the polymer leaflets 106 .
- Mandrel 900 can be designed to have a complementary geometry to the desired leaflet shape and permits easier viewing of leaflet geometry. Although mandrel 900 is utilized to describe the geometry of the leaflet 106 , it should be recognized that the upstream surface of the resulting leaflets will have this geometry when formed by dip coating and that the complementary geometry of the leaflet(s) 106 can be produced using techniques other than dip coating.
- Mandrel 900 is preferably cylindrical and can have an outer profile substantially approximating an inner profile of stent 102 .
- Mandrel 900 can define a plurality of pockets 902 that each define a leaflet 106 as it hangs from wall 104 via attachment line 108 .
- Each leaflet 106 terminates in a commissure line 904 often, but not necessarily lying in a plane at the point where the elliptical or parabolic curve ends and where the leaflet often contacts the other leaflets.
- a substantially vertical coaptation region 906 can extend beyond the commissure line 904 to an extended commissure line 912 for improved sealing as will be discussed herein.
- mandrel can be cast, machined, printed, or otherwise fabricated so that pockets 902 have a desired geometry.
- the commissure line 904 (and optionally the coaptation region 906 and extended commissure line 912 ) has a substantially hyperbolic profile when viewed in the x-y plane.
- leaflet-stent attachment line 108 and/or a leaflet valley line 908 (formed by taking a cross-section in a z plane) can have substantially elliptical profiles.
- elliptical profiles better promote a secure pocket shape and the closure of the leaflet-stent attachment line 108 to the contour of the cylindrical mandrel 900 .
- a comparison of elliptical vs. parabolic leaflet valley lines is provided in FIG. 10A .
- a comparison of elliptical vs. parabolic leaflet-stent attachment lines is provided in FIGS. 10B and 10C .
- mandrel 900 can define a gap 910 between adjacent leaflets.
- leaflets 106 with a hyperbolic profile can produce smaller gaps than leaflets with parabolic profiles.
- gaps 910 can be less than 1 mm or between about 0.1 mm and about 1 mm (e.g., between about 0.1 mm and about 0.2 mm, between about 0.2 mm and about 0.3 mm, between about 0.3 mm and about 0.4 mm, between about 0.4 mm and about 0.5 mm, between about 0.5 mm and about 0.6 mm, between about 0.6 mm and about 0.7 mm, between about 0.7 mm and about 0.8 mm, about 0.8 mm and about 0.9 mm, about 0.9 mm and about 1 mm, and the like).
- the length of hyperbolic commissure line 904 is about twice the radius of the stent or mandrel.
- the positioning of a hyperbolic commissure line 904 relative to defined asymptotes is depicted in FIG. 9F .
- coaptation region can have minimal height in the z-axis so as to consist only of the commissure line 904 .
- coaptation region 906 can have a vertical extension in the z-axis to an extended commissure line 912 as depicted in FIGS. 11B-11D .
- the height of the coaptation region 906 can be selected to reduce the amount of regurgitation, while still allowing the valve to open.
- the coaptation region 906 can have a height between about 1 mm and about 10 mm (e.g., about 3 mm).
- 11B-11D depict extensions of coaptation region 904 that extend solely in the z-axis, the same effect can be achieved using a smooth leaflet-stent attachment line that extends in the z-axis so that the adjacent leaflet-stent attachment lines (and/or the regions of leaflets hanging therebetween) approach and/or contact each other to form an extended coaptation region.
- the zone of coaptation is affected by the pressure placed upon the closed valve 100 .
- Proper coaptation also allows the leaflets 106 to support each other, so there is less stress placed on any individual leaflet 106 .
- Another benefit of enhancing height of the coaptation zone is that this allows the valve 100 to be re-dilated to a larger diameter late after implantation (such as to accommodate growth of a pediatric patient), while still maintaining competence of the valve 100 .
- Options for enhancing the height of the coaptation zone include creating excess length of the leaflet free edges, so that the free edge length is greater than twice the radius of the stent or mandrel depicted in FIG. 9E . Lengthening of the leaflet free edges can be accomplished by curved edges in the x-y plane, or in the z-axis, or in all 3 axes.
- coaptation regions 906 can have varying heights in the z-axis between the commissure line 904 and extended commissure line 912 .
- the height of coaptation region 906 can increase toward the outside of the mandrel as depicted in FIG. 12B .
- the height of the coaptation region 906 can dip to form a trough between the outside and the center of the mandrel 900 as depicted in FIG. 12C .
- the commissure lines 904 , coaptation regions 906 and/or extended commissure lines 912 can have curved profiles in an x-y plane (as opposed to a substantially hyperbolic profile) in order to increase the length of the commissure line 904 , coaptation region 906 , and/or extended commissure line 912 .
- the mandrel 900 can be thicker between the perimeter and the center as depicted in FIG. 12I to produce one or more scallops.
- the mandrel 900 can have either a single curve or multiple curves.
- the thickness of the leaflets 106 can be controlled regionally. Because the most common failure points are at the outer edges of the leaflets 106 (such as commissure line 904 or extended commissure line 912 and leaflet-stent attachment line 108 ), increased thickness at outer areas of the leaflets 106 can improve the strength and durability. Also, if local areas are expected to have concentrated stress, the areas can be locally reinforced (e.g., made thicker than other areas). The thickness can be smoothly increased.
- the width of thickened area along leaflet-stent attachment line 108 can be large enough to cover the glued area for bonding the leaflets 106 and the covered stent 102 .
- the thickness of thickened areas of the leaflets is between about 0.1 mm and about 1 mm.
- the thickness of the leaflets is between about 0.01 mm and about 0.2 mm.
- Different reinforcing materials such as strips, fibers and particles can be placed between the layers, or directly mixed into the polymer solution.
- the inserted material(s) can prevent tearing and reduce propagation of the tear if it occurs.
- the materials can have directional properties and can be layered onto, or embedded into, the leaflets in an optimal direction to prevent or limit tears.
- a reinforcing zone 1302 can be formed on the mandrel 900 prior either by removing mandrel material to allow for additional thickness in certain (e.g., outer) regions of leaflets 106 or by introducing one or more reinforcing fibers prior to, during, or after dip coating.
- Suitable reinforcing materials include fibers (e.g., polymers, nanotubules, aramids, para-aramids, and the like), wires, and the like. Transitions between reinforced and non-reinforced areas can be smooth in order to minimize any turbulence in the implanted valve 100 .
- the coated polymer After dipping the mandrel 900 into the polymer solution, the coated polymer dries in order to form the leaflet(s) 106 . Because the formed leaflets 106 are connected, they need to be separated from each other. These can be cut by a sharp cutter (e.g., a knife, a scalpel, a razor blade, a utility knife, and the like), a heated iron, a laser, a rotary tool, and the like.
- a guide on the top surface of the mandrel for cutting provides a clear, easy, and safe cutting path.
- the guide can be grooved/concave or convex.
- the commissure edges of the mandrel can be sharp like a blade to facilitate leaflet separation and to improve on the quality of the cut edges.
- the gap portion 910 of the mandrel can have various top profiles to facilitate sealing of the leaflets and/or separation of the leaflets prior to removal from mandrel 900 .
- the gap portion 910 can have a grooved profile as depicted in FIG. 14A , a concave profile as depicted in FIG. 14B , or an angled profile as depicted in FIG. 14C .
- a heating element e.g., an Ohmic or resistive heating element such as a wire
- the stent-mounted valve 100 can be implanted with smaller diameter than its manufactured diameter for reducing leakage and improving durability.
- FIGS. 15A, 15B, and 16 a method for fabricating a valve is depicted.
- a bare stent 102 and a bare mandrel 900 are provided.
- the stent 102 can be first coated with a polymer such as PEEK or other metal surface modifier prior to further dip coating of the stent 102 in another polymer in order to improve adhesion of the leaflet polymer 106 to the metal stent 102 .
- a polymer such as PEEK or other metal surface modifier
- the bare mandrel 900 can optionally be coated with a release agent to promote separation of the polymer leaflets from the mandrel 900 .
- Both the bare stent 102 and the mandrel 900 are dip coated separately in a polymer, which may be the same or different for the bare stent 102 and the mandrel 900 .
- the leaflets 106 formed on the mandrel 900 can be removed prior to introduction to the coated stent.
- the coated mandrel 900 can be introduced into the coated stent, the leaflets 106 can be bonded to the coated stent, and the mandrel 900 can be then be removed to leave the assembled valve 100 .
- Leaflets 106 can be bonded to the dip-coated stent using a variety of techniques including gluing, chemical fusing (i.e., dissolving the polymers) thermal fusing, sonic welding, stitching, mechanical fastening, and the like.
- gluing i.e., dissolving the polymers
- thermal fusing i.e., thermal fusing
- sonic welding i.e., sonic welding
- stitching i.e., stitching, mechanical fastening, and the like.
- the entire valve could be formed in a single dip coating (or series of dip coatings) through use of production-grade manufacturing techniques and other optimizations.
- dipcoating was successfully used to fabricate prototypes of the valves described herein, any other manufacturing technique capable of producing flexible leaflets can be utilized.
- Exemplary techniques include injection molding and additive manufacturing or 3D printing.
- stent 102 and leaflets 106 can be fabricated based on a diameter that is slightly larger than the placement location as depicted in FIG. 17A .
- the leaflets 106 When deployed to a location having a smaller diameter than the manufactured diameter, the leaflets 106 will be held in tight contact with each other as seen in FIG. 17B to form a tight seal.
- the deployed diameter In order to form a press fit with the vessel wall, the deployed diameter will be greater than the vessel diameter, but less than the manufactured diameter.
- the coaptation regions of leaflets 106 have a substantially hyperbolic profile both at the manufactured diameter and the deployed diameter.
- FIG. 17C a high-speed photograph of a closed valve under pressure during in vitro testing in a hemodynamic pulse duplicator is provided.
- the leaflets 106 can be formed from the same or different polymer with which the stent 102 is coated to form wall 104 .
- the leaflets 106 can be formed from polymers such as polyethylene, polyurethane, silicone, and the like.
- Wall 104 can be formed from polyethylene, polyurethane, silicone, and the like.
- Supplementary materials such as directional fibers can mixed into the polymer solution or applied to the leaflets between coatings in order to increase durability
- the selected polymer can be dissolved by a solvent such as tetrahydrofuran or dimethylacetamide.
- the thickness of the coated polymer can be controlled as a function of the density of the polymer solution and total number of dippings. When the polymer becomes dry after dipping, the coated stent and mandrel can be placed horizontally and axially rotated in order to produce a constant thickness and prevent the polymer from dripping.
- the valve to be implanted can be a valve 100 as described herein.
- step S 1802 the valve is placed over an expander and within a sheath.
- Various surgical expanders and access devices exist in the cardiac surgery field.
- a balloon catheter could be introduced into a patient's femoral artery and guided to the location of the implanted valve (e.g., within the patient's heart or systemic veins).
- step S 1804 the sheath (containing the valve and the expander) is introduced into a vessel of the subject.
- step S 1806 the valve and the expander are advanced from the sheath and positioned in the desired location.
- step S 1808 the desired positioning can be verified using various imaging techniques such as fiber optics, ultrasound, X-ray, and the like.
- step S 1810 the expander is actuated within the valve to expand the valve to form a press fit against the vessel in which the valve is implanted.
- a balloon catheter can be expanded by introducing gas or a liquid into the balloon.
- step S 1812 the desired positioning and expansion can be verified using various imaging techniques such as fiber optics, ultrasound, X-ray, and the like.
- step S 1814 the expander and sheath can be retracted according to standard surgical techniques.
- the implanted valve can be a valve 100 as described herein.
- step S 1902 an expander is introduced into the implanted valve.
- step S 1904 the expander is actuated within the implanted valve to increase the diameter of the implanted valve.
- step S 1906 the desired expansion can be verified using various imaging techniques.
- step S 1908 the expander can be retracted according to standard surgical techniques.
- embodiments of the invention are described and depicted in the context of percutaneous, transcatheter valves having expandable, cylindrical stents
- embodiments of the invention described herein can be applied to surgically-implanted valves that generally include anchors having fixed-diameter anchors supporting a plurality of leaflets (e.g., the CARPENTIER-EDWARDSTM series of valves available from Edwards Lifesciences Corporation of Irvine, Calif.).
- the anchor replaces the expandable, cylindrical stents described herein.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Prostheses (AREA)
Abstract
One aspect of the invention provides an artificial, flexible valve including: a stent defining a wall and a plurality of leaflets extending from the wall of the stent. The plurality of leaflets form a plurality of coaptation regions between two adjacent leaflets. The coaptation regions include extensions along a z-axis and adapted and are configured to form a releasable, but substantially complete seal when the leaflets are in a closed position. Another aspect of the invention provides an artificial, flexible valve including: a stent defining a wall and a plurality of leaflets extending from the wall of the stent. Each of the plurality of leaflets terminates in a commissure line. The commissure lines deviate from a hyperbola formed in the x-y plane by at least one deviation selected from the group consisting of: a deviation in the z-direction and one or more curves relative to the hyperbola.
Description
- This application claims priority to U.S. Provisional Patent Application Ser. No. 61/989,820, filed May 7, 2014. The entire content of this application is hereby incorporated by reference herein.
- Valves exist in the body (e.g., in the heart and the systemic veins) to allow unidirectional blood flow. A variety of congenital conditions, infectious diseases (e.g., rheumatic heart disease), endocarditis, and age-related impairments (e.g., senile stenosis) can necessitate implantation of an artificial valve.
- One aspect of the invention provides an artificial, flexible valve including: a stent defining a wall and a plurality of leaflets extending from the wall of the stent. The plurality of leaflets form a plurality of coaptation regions between two adjacent leaflets. The coaptation regions include extensions along a z-axis and adapted and are configured to form a releasable, but substantially complete seal when the leaflets are in a closed position.
- This aspect of the invention can have a variety of embodiments. The extensions can have a length along the z-axis between about 1 mm and about 10 mm. The extensions can have a curved profile. The curved profile can lie in an x-y plane. The curved profile can be a variance in extension length along the z-axis.
- The coaptation regions can have a substantially hyperbolic profile. Each of the plurality of leaflets can have a substantially elliptical leaflet-stent attachment line. The stent can be an expandable, cylindrical stent. The leaflets can be reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers. One or more selected from the group consisting of: coaptation regions and leaflet-stent attachment lines can be reinforced with one or more selected from the group consisting of: additional polymer thickness, reinforcing materials, and directional fibers.
- Adjacent leaflets can be coupled to a wide post of the stent. The wide post can include one or more windows. The wide post can have a width between about 0.5 mm and about 3 mm.
- The stent can include metal or plastic. The metal can be selected from the group consisting of: stainless steel, 316L stainless steel, cobalt-chromium alloys, and nickel-titanium alloys.
- The leaflets can be formed from a first polymer. The first polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
- The stent can be dip-coated in a second polymer. The second polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof. The leaflets can be coupled to the second polymer. The leaflets can be mechanically coupled to the second polymer. The leaflets can be chemically coupled to the second polymer. The leaflets can be coupled to the second polymer by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
- A leaflet-stent attachment line for each of the plurality of leaflets can substantially approximate a frame of the stent. The leaflet-stent attachment line can lie within about 3 mm of the frame of the stent.
- The stent can include one or more anchor points. The anchor points can contain a radio-opaque material.
- The valve can be adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary.
- The valve can be adapted and configured for insertion in a subject's veins in order to treat venous insufficiency. The valve can be adapted and configured for serial expansion as the subject ages.
- Another aspect of the invention provides an artificial, flexible valve including: a stent defining a wall and a plurality of leaflets extending from the wall of the stent. Each of the plurality of leaflets terminates in a commissure line. The commissure lines deviate from a hyperbola formed in the x-y plane by at least one deviation selected from the group consisting of: a deviation in the z-direction and one or more curves relative to the hyperbola.
- This aspect of the invention can have a variety of embodiments. The leaflets can further include extensions beyond the commissure lines along a z-axis. The extensions can have a length along the z-axis between about 1 mm and about 10 mm. The extensions can have a curved profile. The curved profile can lie in an x-y plane. The curved profile can be a variance in extension length along the z-axis.
- Each of the plurality of leaflets can have a substantially elliptical leaflet-stent attachment line. The stent can have an expandable, cylindrical stent. The leaflets can be reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers.
- One or more selected from the group consisting of: coaptation regions and leaflet-stent attachment lines can be reinforced with one or more selected from the group consisting of: additional polymer thickness, reinforcing materials, and directional fibers.
- Adjacent leaflets can be coupled to a wide post of the stent. The wide post can include one or more windows. The wide post can have a width between about 0.5 mm and about 3 mm.
- The stent can include metal or plastic. The metal can be selected from the group consisting of: stainless steel, 316L stainless steel, cobalt-chromium alloys, and nickel-titanium alloys.
- The leaflets can be formed from a first polymer. The first polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
- The stent can be dip-coated in a second polymer. The second polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof. The leaflets can be coupled to the second polymer. The leaflets can be mechanically coupled to the second polymer. The leaflets can be chemically coupled to the second polymer. The leaflets can be coupled to the second polymer by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
- A leaflet-stent attachment line for each of the plurality of leaflets can substantially approximate a frame of the stent. The leaflet-stent attachment line can lie within about 3 mm of the frame of the stent.
- The stent can include one or more anchor points. The anchor points can contain a radio-opaque material.
- The valve can be adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary.
- The valve can be adapted and configured for insertion in a subject's veins in order to treat venous insufficiency. The valve can be adapted and configured for serial expansion as the subject ages.
- Another aspect of the invention provides an artificial, flexible valve including: an expandable, cylindrical stent defining a wall and a plurality of leaflets extending from the wall of the stent. Adjacent leaflets can be coupled to a relatively wide post of the stent.
- The leaflets can further include extensions beyond the commissure lines along a z-axis. The extensions can have a length along the z-axis between about 1 mm and about 10 mm. The extensions can have a curved profile. The curved profile can lie in an x-y plane. The curved profile can be a variance in extension length along the z-axis.
- The coaptation regions can have a substantially hyperbolic profile. Each of the plurality of leaflets can have a substantially elliptical leaflet-stent attachment line. The leaflets can be reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers.
- One or more selected from the group consisting of: coaptation regions and leaflet-stent attachment lines can be reinforced with one or more selected from the group consisting of: additional polymer thickness, reinforcing materials, and directional fibers.
- The relatively wide post can include one or more windows. The relatively wide post can have a width between about 0.5 mm and about 3 mm.
- The stent can include metal or plastic. The metal can be selected from the group consisting of: stainless steel, 316L stainless steel, cobalt-chromium alloys, and nickel-titanium alloys.
- The leaflets can be formed from a first polymer. The first polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
- The stent can be dip-coated in a second polymer. The second polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof. The leaflets can be coupled to the second polymer. The leaflets can be mechanically coupled to the second polymer. The leaflets can be chemically coupled to the second polymer. The leaflets can be coupled to the second polymer by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
- A leaflet-stent attachment line for each of the plurality of leaflets can substantially approximate a frame of the stent. The leaflet-stent attachment line can lie within about 3 mm of the frame of the stent.
- The stent can include one or more anchor points. The anchor points can contain a radio-opaque material.
- The valve can be adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary. The valve can be adapted and configured for insertion in a subject's veins in order to treat venous insufficiency. The valve can be adapted and configured for serial expansion as the subject ages. The valve may not contain any animal-derived materials.
- Another aspect of the invention provides a mandrel including: a cylindrical profile and a plurality of recesses adapted and configured to define a plurality of leaflets forming a plurality of coaptation regions between two adjacent leaflets. The coaptation regions can include extensions along a z-axis and be adapted and configured to form a releasable, but substantially complete seal when the leaflets are in a closed position.
- This aspect of the invention can have a variety of embodiments. The mandrel can include one more cutting guides located between the plurality of recesses. The mandrel can include one or more heating elements.
- Another aspect of the invention provides a mandrel including: a cylindrical profile and a plurality of recesses adapted and configured to define a plurality of leaflets. Each of the plurality of leaflets terminate in a commissure line. The commissure lines deviate from a hyperbola formed in the x-y plane by at least one deviation selected from the group consisting of: a deviation in the z-direction and one or more curves relative to the hyperbola.
- This aspect of the invention can have a variety of embodiments. The mandrel can include one more cutting guides located between the plurality of recesses. The mandrel can include one or more heating elements.
- Another aspect of the invention provides a method for fabricating an artificial, flexible valve. The method includes: dip coating a cylindrical mandrel having a plurality of recesses each approximating a profile of a leaflet and coupling the leaflets to an inner wall of a stent.
- This aspect of the invention can have a variety of embodiments. The method can further include dip coating the stent prior to coupling the leaflets to the inner wall of the stent. The stent and the mandrel can have larger diameters than a target location for the valve. The method can further include separating adjacent leaflets from each other.
- For a fuller understanding of the nature and desired objects of the present invention, reference is made to the following detailed description taken in conjunction with the accompanying drawing figures wherein like reference characters denote corresponding parts throughout the several views and wherein:
-
FIGS. 1A and 1B provide perspective (in which fluid flows from the bottom of the stent toward the top of the stent) and top (in which fluid flows out of the page when the valve is open and flows down into the page to close the valve) views of a valve according to an embodiment of the invention; -
FIG. 2 depicts a stent according to an embodiment of the invention; -
FIGS. 3A-3F depict various stent geometries according to embodiments of the invention; -
FIG. 4 depicts various vertical post geometries according to embodiments of the invention; -
FIGS. 5A-5D depict the positioning of a leaflet joint adjacent to a window of a vertical post according to an embodiment of the invention; -
FIG. 6 depicts a stent prior to expansion, dip coating, and leaflet installation according to an embodiment of the invention; -
FIG. 7 depicts a stent including one or more anchor points according to an embodiment of the invention; -
FIG. 8 depicts the engagement of a stent with a holder for dipping and rotation according to an embodiment of the invention; -
FIGS. 9A-9E depict a mandrel according to an embodiment of the invention; -
FIG. 9F depicts the positioning of a hyperbolic commissure line relative to defined asymptotes according to embodiments of the invention; -
FIG. 10A depicts a comparison of elliptical vs. parabolic geometries leaflet valley lines according to embodiments of the invention; -
FIGS. 10B and 10C depict a comparison of elliptical vs. parabolic leaflet stent attachment lines according to embodiments of the invention; -
FIGS. 11A-11D depict mandrels for forming coaptation regions of varying height according to embodiments of the invention; -
FIGS. 12A-12D depict mandrels for forming coaptation regions of varying radial length according to embodiments of the invention; -
FIGS. 12E-12H depict mandrels for forming commissure lines having variable depths along the z-axis according to embodiments of the invention; -
FIGS. 12I-12K depict mandrels for forming coaptation regions having curved profiles in an x-y plane, resulting in increased coaptation length, according to embodiments of the invention; -
FIGS. 12L-12N depict mandrels for forming commissure lines having curved profiles in an x-y plane, resulting in increased coaptation length, according to embodiments of the invention; -
FIG. 13A depicts a mandrel according to an embodiment of the invention; -
FIGS. 13B and 13C depict the positioning of reinforcing zones on a mandrel according to an embodiment of the invention; -
FIGS. 14A-14C depict various top profiles according to an embodiment of the invention; -
FIGS. 15A and 15B depict the fabrication of valves according to embodiments of the invention; -
FIG. 16 depict the fabrication of valves according to an embodiment of the invention; -
FIGS. 17A and 17B depict the compression of a valve after assembly in order to bring leaflets into contact with each other according to embodiments of the invention; -
FIG. 17C is a high-speed photograph of a closed valve under pressure according to embodiments of the invention; -
FIG. 18 depicts a method of implanting a valve according to embodiments of the invention; and -
FIG. 19 depicts a method of expanding an implanted valve according to embodiments of the invention. - The instant invention is most clearly understood with reference to the following definitions.
- As used herein, the singular form “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
- Unless specifically stated or obvious from context, as used herein, the term “about” is understood as within a range of normal tolerance in the art, for example within 2 standard deviations of the mean. “About” can be understood as within 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.05%, or 0.01% of the stated value. Unless otherwise clear from context, all numerical values provided herein are modified by the term about.
- As used in the specification and claims, the terms “comprises,” “comprising,” “containing,” “having,” and the like can have the meaning ascribed to them in U.S. patent law and can mean “includes,” “including,” and the like.
- Unless specifically stated or obvious from context, the term “or,” as used herein, is understood to be inclusive.
- Ranges provided herein are understood to be shorthand for all of the values within the range. For example, a range of 1 to 50 is understood to include any number, combination of numbers, or sub-range from the group consisting 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 (as well as fractions thereof unless the context clearly dictates otherwise).
- Aspects of the invention provide a novel platform that allows development of polymeric valves of any size and shape. Aspects of the invention can be applied to valves designed for surgical implantation (e.g., through a sternotomy or thoracotomy) or valves designed for percutaneous, transcatheter implantation. Additionally, embodiments of the invention allow for possible percutaneous replacement of a dysfunctional valve, whether in adults or in small children. In addition, if implanted in a child, embodiments of the invention allow the valve to be serially expanded to accompany the child's growth.
- Multiple types of congenital heart defects require heart valve replacement surgery in infancy or childhood. In adults, the most commonly replaced valves are aortic and mitral, whereas in children, the pulmonary valve is the most commonly replaced valve. Heart valves are currently replaced using tissue valves (homograft or xenograft) or mechanical metal valves, each having their shortcomings. Homograft valves are in short supply, particularly in sizes suitable for use in children, and biologic tissue-based valves (whether bovine, porcine, or homograft) tend to induce an immunologic reaction which leads to failure of these valves. Mechanical valves generally require anticoagulation, and are almost never used in the pulmonary position due to an increased risk of thrombosis.
- Furthermore, none of the surgically implanted valves can adapt to growing patients. The rapid growth of pediatric patients leads them to outgrow their implanted valves within a few years and induces a cycle of frequent surgical valve replacements during childhood. Aspects of the invention provide valves having improved biocompatibility, durability, and hemodynamic performance and would reduce the frequency of recurrent open heart surgeries for valve replacement.
- Additionally, aspects of the invention can be used for venous valve replacement in patients having venous disease such as chronic venous insufficiency (leading to leg swelling). Because the polymer leaflets can be made extremely thin, the valves can even open under extremely low venous pressure gradients.
- Referring now to
FIGS. 1A and 1B , one aspect of the invention provides an artificial,flexible valve 100. The valve includes an expandable,cylindrical stent 102 defining awall 104.Valve 100 further includes a plurality ofleaflets 106 a-106 c.Wall 104 can be formed bydip coating stent 102 in a polymer as further described herein.Leaflets 106 can be coupled towall 104 alongseams 108 using a variety of approaches (e.g., glue) as discussed further herein.Stent 102 can include one or morevertical posts 110, 112, which can be relatively narrow posts 110 or relatively wide posts 112. Preferably leaflet joints betweenadjacent leaflets 106 are positioned on or close to avertical post 110, 112 of thestent 102. - The
valve 100 will now be described in the context of its components and methods of fabrication. - Referring now to
FIG. 2 ,stent 102 can be a metallic stent having plurality of wires, strips, and the like 202 defining a plurality ofcells Stent 102 can be fabricated from a variety of malleable materials such as stainless steel, 316L stainless steel, cobalt-chromium alloys, nickel-titanium alloys (colloquially known as “nitinol”), and the like.Stent 102 can also be formed from various non-metallic materials such as plastics such as polyethylene, polyurethane, polytetrafluoroethylene (PTFE), silicone, poly(propylene) (PP), polyethylene terephthalate (PET), and the like. -
Stent 102 can be completely enveloped by a polymer dip coating.Stent 102 and/orwall 104 can also be fabricated from a biocompatible material. - The
stent 102 can be manufactured by laser cutting or wire forming. To increase bonding strength between metal and polymer, roughness of stent surface can be controlled. Some or allopen cells -
FIG. 6 depicts astent 102 prior to expansion, dip coating, and leaflet installation.Stents 102 typically have a diameter of between about 2 mm and 6 mm prior to expansion and can be expanded to between about 5 mm and about 30 mm for implantation into a subject. - The components of
stent 102 can have a variety of dimensions that can be selected to achieve a desired flexibility, rigidity, resilience, and the like. For example, the thickness and width of components of thestent 102 can be between about 0.1 mm and about 2 mm. - As discussed above,
stent 102 can include one or more vertical posts 110 a-110 c to enhance bonding withleaflets 106. -
Stent 102 can include a plurality of vertical posts 110 that can serve a variety of functions. Some vertical posts 110 can include additional structure and are referred to herein aswide posts 112.Wide posts 112 are preferably located at leaflet joints where twoleaflets 106 meet. For example, in avalve 100 having a threeleaflets 106,wide posts 112 can be positioned at 120° intervals withincylindrical stent 102. -
Wide posts 112 provide mechanical support to leaflets and prevent or substantially limit inward deformation ofwall 104 due to tensile forces applied toleaflets 106 transferred towall 104. Without being bound by theory, it is believed that thewide posts 112 provide increased strength and resiliency due to formation ofpolymer wall 104 throughwindows 206 and aroundwide posts 112, thus providing cohesive holding of the polymer to itself around thestent 102 instead of relying solely on adhesive bonding of thepolymer wall 104 to thestent 102. -
Wide posts 112 advantageously allow for relaxed tolerances inpositioning leaflets 106 relative towide posts 112. For example,window 208 can have a width of between about 0.5 mm and about 3 mm (e.g., about 1 mm) and a height of between about 1 mm and about 10 mm (e.g., about 5 mm). - A variety of additional wide post geometries are depicts in
FIGS. 3A-3F . InFIG. 3A , the wide posts have a solid architecture without any windows. InFIG. 3B , the wide posts have a substantially rectangular architecture defining a single, long window as inFIGS. 1A, 1B, and 2 . InFIG. 3C , the wide posts define a plurality of coaxial substantially rectangular windows. InFIG. 3D , the wide posts define a plurality of coaxial, substantially parallel windows. InFIG. 3E , the wide posts define a plurality of coaxial, substantially rectangular windows in a 2×3 arrangement. InFIG. 3F , the wide posts include a plurality of circular windows. These wide post architectures are further depicted inFIG. 4 . Although substantially circular and rectangular window geometries are depicted, any geometry can be utilized including windows having a profile approximating a triangle, a square, an n-gon (e.g., a hexagon, an octagon, and the like), and the like. - Referring now to
FIGS. 5A-5D , the positioning of a leaflet joint 502 (formed, e.g., onmandrel 900 as discussed herein) adjacent towindow 206 ofwide post 112 is depicted. (The polymer dip-coatedwall 104 is completely transparent for ease and clarity in viewing, but can be transparent, translucent, or opaque.)FIG. 5B-5D further depict how a geometry of thestent 102 can be selected to substantially approximate the leaflet-stent attachment seam 108 discussed herein in order to provide added mechanical support and resiliency. - Referring now to
FIG. 7 ,stent 102 can include one or more anchor points 702. Anchor points 702 advantageously facilitate holding, dipping, and rotation of thestent 102 during the dip coating process without interfering with the dip coating of the remainder of the stent architecture. Accordingly, theentire stent 102 can be dip coated in a single dipping, although multiple dippings can be utilized to control coating density, thickness, and the like. Anchor points 702 can also receive one or more radio-opaque materials such as platinum to aid in placement and visualization of the valve. - In one embodiments depicted in
FIG. 8 ,stent 102 can be engaged with a holder 802 (e.g., by posts 804) for dipping and rotation. Once the polymer (again depicted as, but not necessarily, transparent) is wet on thestent 102, the stent can be positioned horizontally and rotated axially. -
Leaflets 106 can be formed using a variety of techniques including dip coating, 3D-printing (also known as additive manufacturing), molding, and the like. - Referring now to
FIG. 9A ,leaflets 106 can be fabricated by dip coating amandrel 900 with a polymer. Themandrel 900 can be made with a solid such as a metal (e.g., stainless steel, titanium, aluminum, and the like), a plastic (e.g., polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroethylene, polyoxymethylene, and the like), and the like. Since thecoated polymer leaflets 106 will be removed from themandrel 900 after the polymer dries, roughness of mandrel surface can be controlled using known machining and other manufacturing techniques. Themandrel 900 can be made from a cylinder. Preferably, the diameter of themandrel 900 is a slightly (e.g., between about 0.05 and about 0.4 mm) smaller than inner diameter ofstent 102 after expansion. - The
mandrel 900 for theleaflets 106 can have novel features, including edges representing the leaflet attachment points that are mathematically defined and leaflet tips that are extended in order to increase the coaptation length of the leaflets. Themandrel 900 can be dimensioned to produceleaflets 106 having different regional thickness and supplementary materials such as directional fibers or reinforcing particles inserted between layers or mixed into the polymer solution in order to increase durability. For example, polymer interaction with particles on the nanoscale or microscale can greatly improve the physical properties or tear resistance of thepolymer leaflets 106. -
Mandrel 900 can be designed to have a complementary geometry to the desired leaflet shape and permits easier viewing of leaflet geometry. Althoughmandrel 900 is utilized to describe the geometry of theleaflet 106, it should be recognized that the upstream surface of the resulting leaflets will have this geometry when formed by dip coating and that the complementary geometry of the leaflet(s) 106 can be produced using techniques other than dip coating.Mandrel 900 is preferably cylindrical and can have an outer profile substantially approximating an inner profile ofstent 102.Mandrel 900 can define a plurality ofpockets 902 that each define aleaflet 106 as it hangs fromwall 104 viaattachment line 108. Eachleaflet 106 terminates in acommissure line 904 often, but not necessarily lying in a plane at the point where the elliptical or parabolic curve ends and where the leaflet often contacts the other leaflets. A substantiallyvertical coaptation region 906 can extend beyond thecommissure line 904 to anextended commissure line 912 for improved sealing as will be discussed herein. - Referring now to
FIGS. 9B and 9C , mandrel can be cast, machined, printed, or otherwise fabricated so thatpockets 902 have a desired geometry. In one embodiment of the invention, the commissure line 904 (and optionally thecoaptation region 906 and extended commissure line 912) has a substantially hyperbolic profile when viewed in the x-y plane. Additionally or alternatively, leaflet-stent attachment line 108 and/or a leaflet valley line 908 (formed by taking a cross-section in a z plane) can have substantially elliptical profiles. Although other quadratic profiles (e.g., parabolic) could be used, elliptical profiles better promote a secure pocket shape and the closure of the leaflet-stent attachment line 108 to the contour of thecylindrical mandrel 900. A comparison of elliptical vs. parabolic leaflet valley lines is provided inFIG. 10A . A comparison of elliptical vs. parabolic leaflet-stent attachment lines is provided inFIGS. 10B and 10C . - Referring now to
FIG. 9D ,mandrel 900 can define agap 910 between adjacent leaflets. Advantageously,leaflets 106 with a hyperbolic profile can produce smaller gaps than leaflets with parabolic profiles. For example,gaps 910 can be less than 1 mm or between about 0.1 mm and about 1 mm (e.g., between about 0.1 mm and about 0.2 mm, between about 0.2 mm and about 0.3 mm, between about 0.3 mm and about 0.4 mm, between about 0.4 mm and about 0.5 mm, between about 0.5 mm and about 0.6 mm, between about 0.6 mm and about 0.7 mm, between about 0.7 mm and about 0.8 mm, about 0.8 mm and about 0.9 mm, about 0.9 mm and about 1 mm, and the like). - As seen in
FIG. 9E , the length ofhyperbolic commissure line 904 is about twice the radius of the stent or mandrel. The positioning of ahyperbolic commissure line 904 relative to defined asymptotes is depicted inFIG. 9F . - Referring now to
FIG. 11A , coaptation region can have minimal height in the z-axis so as to consist only of thecommissure line 904. Alternatively,coaptation region 906 can have a vertical extension in the z-axis to anextended commissure line 912 as depicted inFIGS. 11B-11D . The height of thecoaptation region 906 can be selected to reduce the amount of regurgitation, while still allowing the valve to open. For example thecoaptation region 906 can have a height between about 1 mm and about 10 mm (e.g., about 3 mm). AlthoughFIGS. 11B-11D depict extensions ofcoaptation region 904 that extend solely in the z-axis, the same effect can be achieved using a smooth leaflet-stent attachment line that extends in the z-axis so that the adjacent leaflet-stent attachment lines (and/or the regions of leaflets hanging therebetween) approach and/or contact each other to form an extended coaptation region. - The zone of coaptation is affected by the pressure placed upon the
closed valve 100. The higher the pressure, the more downward tension is placed on theleaflets 106, possibly leading to a failure of coaptation with consequent regurgitation. Proper coaptation also allows theleaflets 106 to support each other, so there is less stress placed on anyindividual leaflet 106. Another benefit of enhancing height of the coaptation zone is that this allows thevalve 100 to be re-dilated to a larger diameter late after implantation (such as to accommodate growth of a pediatric patient), while still maintaining competence of thevalve 100. - Options for enhancing the height of the coaptation zone include creating excess length of the leaflet free edges, so that the free edge length is greater than twice the radius of the stent or mandrel depicted in
FIG. 9E . Lengthening of the leaflet free edges can be accomplished by curved edges in the x-y plane, or in the z-axis, or in all 3 axes. - Referring now to
FIGS. 12A-12D ,coaptation regions 906 can have varying heights in the z-axis between thecommissure line 904 andextended commissure line 912. For example, the height ofcoaptation region 906 can increase toward the outside of the mandrel as depicted inFIG. 12B . In another embodiment, the height of thecoaptation region 906 can dip to form a trough between the outside and the center of themandrel 900 as depicted inFIG. 12C . - Referring now to
FIGS. 12E-12H , the same profiles can be applied tocommissure line 904 without anycoaptation region 906. - Referring now to
FIGS. 12I-12K , thecommissure lines 904,coaptation regions 906 and/orextended commissure lines 912 can have curved profiles in an x-y plane (as opposed to a substantially hyperbolic profile) in order to increase the length of thecommissure line 904,coaptation region 906, and/orextended commissure line 912. For example, themandrel 900 can be thicker between the perimeter and the center as depicted inFIG. 12I to produce one or more scallops. InFIGS. 12J and 12K , themandrel 900 can have either a single curve or multiple curves. - Referring now to
FIGS. 12L-12N , the same profiles can be applied tocommissure line 904 without anycoaptation region 906. - In order to increase tear-resistance of the
leaflets 106 and enhance bonding strength betweenleaflets 106 andstent 102, the thickness of theleaflets 106 can be controlled regionally. Because the most common failure points are at the outer edges of the leaflets 106 (such ascommissure line 904 or extendedcommissure line 912 and leaflet-stent attachment line 108), increased thickness at outer areas of theleaflets 106 can improve the strength and durability. Also, if local areas are expected to have concentrated stress, the areas can be locally reinforced (e.g., made thicker than other areas). The thickness can be smoothly increased. The width of thickened area along leaflet-stent attachment line 108 can be large enough to cover the glued area for bonding theleaflets 106 and the coveredstent 102. In some embodiments, the thickness of thickened areas of the leaflets is between about 0.1 mm and about 1 mm. - Multiple dippings can be performed to produce leaflets with a desired thickness. In some embodiments, the thickness of the leaflets is between about 0.01 mm and about 0.2 mm.
- Different reinforcing materials such as strips, fibers and particles can be placed between the layers, or directly mixed into the polymer solution. The inserted material(s) can prevent tearing and reduce propagation of the tear if it occurs. The materials can have directional properties and can be layered onto, or embedded into, the leaflets in an optimal direction to prevent or limit tears.
- Referring now to
FIG. 13A , a photograph of amandrel 900 is provided. Referring now toFIG. 13B , a reinforcingzone 1302 can be formed on themandrel 900 prior either by removing mandrel material to allow for additional thickness in certain (e.g., outer) regions ofleaflets 106 or by introducing one or more reinforcing fibers prior to, during, or after dip coating. Suitable reinforcing materials include fibers (e.g., polymers, nanotubules, aramids, para-aramids, and the like), wires, and the like. Transitions between reinforced and non-reinforced areas can be smooth in order to minimize any turbulence in the implantedvalve 100. - After dipping the
mandrel 900 into the polymer solution, the coated polymer dries in order to form the leaflet(s) 106. Because the formedleaflets 106 are connected, they need to be separated from each other. These can be cut by a sharp cutter (e.g., a knife, a scalpel, a razor blade, a utility knife, and the like), a heated iron, a laser, a rotary tool, and the like. A guide on the top surface of the mandrel for cutting provides a clear, easy, and safe cutting path. The guide can be grooved/concave or convex. Also, the commissure edges of the mandrel can be sharp like a blade to facilitate leaflet separation and to improve on the quality of the cut edges. - Referring now to
FIG. 14A-14C , thegap portion 910 of the mandrel can have various top profiles to facilitate sealing of the leaflets and/or separation of the leaflets prior to removal frommandrel 900. For example, thegap portion 910 can have a grooved profile as depicted inFIG. 14A , a concave profile as depicted inFIG. 14B , or an angled profile as depicted inFIG. 14C . Additionally or alternatively, a heating element (e.g., an Ohmic or resistive heating element such as a wire) can be included in the mandrel and can be actuated to melt the polymer to separate the leaflets and/or relax the polymer to facilitate removal of the leaflets from themandrel 900. - The stent-mounted
valve 100 can be implanted with smaller diameter than its manufactured diameter for reducing leakage and improving durability. - Referring now to
FIGS. 15A, 15B, and 16 , a method for fabricating a valve is depicted. Abare stent 102 and abare mandrel 900 are provided. - In some embodiments, the
stent 102 can be first coated with a polymer such as PEEK or other metal surface modifier prior to further dip coating of thestent 102 in another polymer in order to improve adhesion of theleaflet polymer 106 to themetal stent 102. - The
bare mandrel 900 can optionally be coated with a release agent to promote separation of the polymer leaflets from themandrel 900. - Both the
bare stent 102 and themandrel 900 are dip coated separately in a polymer, which may be the same or different for thebare stent 102 and themandrel 900. - The
leaflets 106 formed on themandrel 900 can be removed prior to introduction to the coated stent. Alternatively, thecoated mandrel 900 can be introduced into the coated stent, theleaflets 106 can be bonded to the coated stent, and themandrel 900 can be then be removed to leave the assembledvalve 100. -
Leaflets 106 can be bonded to the dip-coated stent using a variety of techniques including gluing, chemical fusing (i.e., dissolving the polymers) thermal fusing, sonic welding, stitching, mechanical fastening, and the like. For example, the same polymer solution used to coat eitherbare stent 102 and/ormandrel 900 can be applied to bond theleaflets 106 to the dip-coated stent. - Although separate fabrication of the polymer-coated stent and the
leaflets 106 are currently preferred as a means of avoiding or minimizing air bubbles, the entire valve could be formed in a single dip coating (or series of dip coatings) through use of production-grade manufacturing techniques and other optimizations. - Although dipcoating was successfully used to fabricate prototypes of the valves described herein, any other manufacturing technique capable of producing flexible leaflets can be utilized. Exemplary techniques include injection molding and additive manufacturing or 3D printing.
- Referring now to
FIGS. 17A and 17B ,stent 102 andleaflets 106 can be fabricated based on a diameter that is slightly larger than the placement location as depicted inFIG. 17A . When deployed to a location having a smaller diameter than the manufactured diameter, theleaflets 106 will be held in tight contact with each other as seen inFIG. 17B to form a tight seal. (In order to form a press fit with the vessel wall, the deployed diameter will be greater than the vessel diameter, but less than the manufactured diameter.) - As can be seen in
FIGS. 17A and 17B , the coaptation regions ofleaflets 106 have a substantially hyperbolic profile both at the manufactured diameter and the deployed diameter. - Referring now to
FIG. 17C , a high-speed photograph of a closed valve under pressure during in vitro testing in a hemodynamic pulse duplicator is provided. - The
leaflets 106 can be formed from the same or different polymer with which thestent 102 is coated to formwall 104. For example, theleaflets 106 can be formed from polymers such as polyethylene, polyurethane, silicone, and the like.Wall 104 can be formed from polyethylene, polyurethane, silicone, and the like. - Supplementary materials such as directional fibers can mixed into the polymer solution or applied to the leaflets between coatings in order to increase durability
- The selected polymer can be dissolved by a solvent such as tetrahydrofuran or dimethylacetamide. The thickness of the coated polymer can be controlled as a function of the density of the polymer solution and total number of dippings. When the polymer becomes dry after dipping, the coated stent and mandrel can be placed horizontally and axially rotated in order to produce a constant thickness and prevent the polymer from dripping.
- Referring now to
FIG. 18 , amethod 1800 of implanting an artificial valve is provided. The valve to be implanted can be avalve 100 as described herein. - In step S1802, the valve is placed over an expander and within a sheath. Various surgical expanders and access devices exist in the cardiac surgery field. For example, a balloon catheter could be introduced into a patient's femoral artery and guided to the location of the implanted valve (e.g., within the patient's heart or systemic veins).
- In step S1804, the sheath (containing the valve and the expander) is introduced into a vessel of the subject.
- In step S1806, the valve and the expander are advanced from the sheath and positioned in the desired location.
- In step S1808, the desired positioning can be verified using various imaging techniques such as fiber optics, ultrasound, X-ray, and the like.
- In step S1810, the expander is actuated within the valve to expand the valve to form a press fit against the vessel in which the valve is implanted. For example, a balloon catheter can be expanded by introducing gas or a liquid into the balloon.
- In step S1812, the desired positioning and expansion can be verified using various imaging techniques such as fiber optics, ultrasound, X-ray, and the like.
- In step S1814, the expander and sheath can be retracted according to standard surgical techniques.
- Referring now to
FIG. 19 , amethod 1900 of expanding an implanted valve is provided. The implanted valve can be avalve 100 as described herein. - In step S1902, an expander is introduced into the implanted valve.
- In step S1904, the expander is actuated within the implanted valve to increase the diameter of the implanted valve.
- In step S1906, the desired expansion can be verified using various imaging techniques.
- In step S1908, the expander can be retracted according to standard surgical techniques.
- Although embodiments of the invention are described and depicted in the context of percutaneous, transcatheter valves having expandable, cylindrical stents, embodiments of the invention described herein can be applied to surgically-implanted valves that generally include anchors having fixed-diameter anchors supporting a plurality of leaflets (e.g., the CARPENTIER-EDWARDS™ series of valves available from Edwards Lifesciences Corporation of Irvine, Calif.). In such embodiments, the anchor replaces the expandable, cylindrical stents described herein.
- Although preferred embodiments of the invention have been described using specific terms, such description is for illustrative purposes only, and it is to be understood that changes and variations may be made without departing from the spirit or scope of the following claims.
- The entire contents of all patents, published patent applications, and other references cited herein are hereby expressly incorporated herein in their entireties by reference.
Claims (34)
1. An artificial, flexible valve comprising:
a stent defining a wall; and
a plurality of leaflets extending from the wall of the stent, the plurality of leaflets forming a plurality of coaptation regions between two adjacent leaflets, the coaptation regions each having a substantially hyperbolic profile including extensions along a z-axis and adapted and configured to form a releasable, but substantially complete seal when the leaflets are in a closed position.
2. The valve of claim 1 , wherein the extensions have a length along the z-axis between about 1 mm and about 10 mm.
3. The valve of claim 1 , wherein the extensions have a curved profile.
4. The valve of claim 3 , wherein the curved profile lies in an x-y plane.
5. The valve of claim 3 , wherein the curved profile is a variance in extension length along the z-axis.
6. (canceled)
7. The valve of claim 1 , wherein each of the plurality of leaflets has a substantially elliptical leaflet-stent attachment line.
8. (canceled)
9. The valve of claim 1 , wherein one or more from the group consisting of: the leaflets, the coaptation regions, and the leaflet stent attachment lines are reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers.
10. (canceled)
11. The valve of claim 1 , wherein adjacent leaflets are coupled to a wide post of the stent.
12. The valve of claim 11 , wherein the wide post includes one or more windows.
13.-15. (canceled)
16. The valve of claim 1 , wherein:
the leaflets are formed from a first polymer; and
the stent is dip-coated in a second polymer; and
the leaflets are coupled to the second polymer mechanically, chemically, or by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
17.-23. (canceled)
24. The valve of claim 1 , wherein:
a leaflet-stent attachment line for each of the plurality of leaflets substantially approximates a frame of the stent; and
the leaflet-stent attachment line lies within about 3 mm of the frame of the stent.
25. (canceled)
26. The valve of claim 1 , wherein the stent includes one or more anchor points.
27. (canceled)
28. The valve of claim 1 , wherein the valve is adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary or insertion in a subject's veins in order to treat venous insufficiency.
29. (canceled)
30. (canceled)
31. An artificial, flexible valve comprising:
a stent defining a wall; and
a plurality of leaflets extending from the wall of the stent, each of the plurality of leaflets terminating in a commissure line, the commissure lines deviating from a hyperbola formed in the x-y plane by at least one deviation selected from the group consisting of: a deviation in the z-direction and one or more curves relative to the hyperbola.
32.-60. (canceled)
61. An artificial, flexible valve comprising:
an expandable, cylindrical stent defining a wall; and
a plurality of leaflets extending from the wall of the stent, wherein adjacent leaflets are coupled to a relatively wide post of the stent.
62.-90. (canceled)
91. A mandrel comprising:
a cylindrical profile; and
a plurality of recesses adapted and configured to define a plurality of leaflets forming a plurality of coaptation regions between two adjacent leaflets, the coaptation regions including extensions along a z-axis and adapted and configured to form a releasable, but substantially complete seal when the leaflets are in a closed position.
92. The mandrel of claim 91 , further comprising:
one more cutting guides located between the plurality of recesses.
93. The mandrel of claim 91 , further comprising:
one or more heating elements.
94. A mandrel comprising:
a cylindrical profile; and
a plurality of recesses adapted and configured to define a plurality of leaflets, each of the plurality of leaflets terminating in a commissure line, the commissure lines deviating from a hyperbola formed in the x-y plane by at least one deviation selected from the group consisting of: a deviation in the z-direction and one or more curves relative to the hyperbola.
95. (canceled)
96. (canceled)
97. A method for fabricating an artificial, flexible valve, the method comprising:
dip coating a cylindrical mandrel having a plurality of recesses each approximating a profile of a leaflet; and
coupling the leaflets to an inner wall of a stent;
wherein the stent and the mandrel have larger diameters than a target location for the valve.
98.-100. (canceled)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/308,667 US20170189175A1 (en) | 2014-05-07 | 2015-05-06 | Artificial, flexible valves and methods of fabricating and serially expanding the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461989820P | 2014-05-07 | 2014-05-07 | |
US15/308,667 US20170189175A1 (en) | 2014-05-07 | 2015-05-06 | Artificial, flexible valves and methods of fabricating and serially expanding the same |
PCT/US2015/029442 WO2015171743A2 (en) | 2014-05-07 | 2015-05-06 | Artificial, flexible valves and methods of fabricating and serially expanding the same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2015/029442 A-371-Of-International WO2015171743A2 (en) | 2014-05-07 | 2015-05-06 | Artificial, flexible valves and methods of fabricating and serially expanding the same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/563,229 Continuation US20200000581A1 (en) | 2014-05-07 | 2019-09-06 | Artificial, flexible valves and methods of fabricating and serially expanding the same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20170189175A1 true US20170189175A1 (en) | 2017-07-06 |
Family
ID=54393140
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/308,667 Abandoned US20170189175A1 (en) | 2014-05-07 | 2015-05-06 | Artificial, flexible valves and methods of fabricating and serially expanding the same |
US16/563,229 Abandoned US20200000581A1 (en) | 2014-05-07 | 2019-09-06 | Artificial, flexible valves and methods of fabricating and serially expanding the same |
US17/473,653 Active US11464632B2 (en) | 2014-05-07 | 2021-09-13 | Transcatheter and serially-expandable artificial heart valve |
US17/478,665 Active 2035-07-06 US11571300B2 (en) | 2014-05-07 | 2021-09-17 | Serially expanding an artificial heart valve within a pediatric patient |
US17/982,232 Pending US20230135271A1 (en) | 2014-05-07 | 2022-11-07 | Serially expanding an artificial heart valve within a pediatric patient |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/563,229 Abandoned US20200000581A1 (en) | 2014-05-07 | 2019-09-06 | Artificial, flexible valves and methods of fabricating and serially expanding the same |
US17/473,653 Active US11464632B2 (en) | 2014-05-07 | 2021-09-13 | Transcatheter and serially-expandable artificial heart valve |
US17/478,665 Active 2035-07-06 US11571300B2 (en) | 2014-05-07 | 2021-09-17 | Serially expanding an artificial heart valve within a pediatric patient |
US17/982,232 Pending US20230135271A1 (en) | 2014-05-07 | 2022-11-07 | Serially expanding an artificial heart valve within a pediatric patient |
Country Status (4)
Country | Link |
---|---|
US (5) | US20170189175A1 (en) |
EP (1) | EP3139865A4 (en) |
CA (1) | CA2948179C (en) |
WO (1) | WO2015171743A2 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110353858A (en) * | 2018-04-09 | 2019-10-22 | 倍芮医疗器械(上海)有限公司 | For loading the bracket and venous valve displacement apparatus of valve |
US20190343625A1 (en) * | 2017-12-11 | 2019-11-14 | Foldax, Inc. | Systems, devices, and methods relating to the manufacture of intravascularly implantable prosthetic valves |
WO2020191386A1 (en) * | 2019-03-21 | 2020-09-24 | The Trustees Of Columbia University In The City Of New York | Transcatheter dilatable biostable polymeric stented valved tube prosthesis |
CN111818876A (en) * | 2017-11-16 | 2020-10-23 | 儿童医学中心公司 | Geometrically adaptive heart valve replacement device |
US11039919B2 (en) | 2017-10-31 | 2021-06-22 | W. L. Gore & Associates, Inc. | Valved conduit |
US20210338422A1 (en) * | 2017-09-27 | 2021-11-04 | W. L. Gore & Associates, Inc. | Prosthetic valves with mechanically coupled leaflets |
WO2022066961A1 (en) * | 2020-09-23 | 2022-03-31 | ReValve Solutions Inc. | Devices, systems, and methods for an implantable heart-valve adapter |
US11351058B2 (en) | 2017-03-17 | 2022-06-07 | W. L. Gore & Associates, Inc. | Glaucoma treatment systems and methods |
US11464632B2 (en) * | 2014-05-07 | 2022-10-11 | Baylor College Of Medicine | Transcatheter and serially-expandable artificial heart valve |
US11547557B2 (en) | 2018-12-13 | 2023-01-10 | Abbott Laboratories | Stabilized fabric material for medical devices |
USD977642S1 (en) | 2018-10-29 | 2023-02-07 | W. L. Gore & Associates, Inc. | Pulmonary valve conduit |
US11617644B2 (en) | 2014-10-13 | 2023-04-04 | W. L. Gore & Associates, Inc. | Prosthetic valved conduit |
WO2023060330A1 (en) * | 2021-10-15 | 2023-04-20 | Angel Maluf Miguel | Polyurethane-coated, expandable stented valve prosthesis designed with anatomic cusps for implanting by catheter in the pulmonary position in pediatric and adult patients, and method for producing expandable stented valve prosthesis |
WO2023095033A1 (en) * | 2021-11-23 | 2023-06-01 | Medtronic, Inc. | Leaflet design for a heart valve prosthesis |
US11678983B2 (en) | 2018-12-12 | 2023-06-20 | W. L. Gore & Associates, Inc. | Implantable component with socket |
US11969342B2 (en) | 2022-08-03 | 2024-04-30 | The Children's Medical Center Corporation | Geometrically-accommodating heart valve replacement device |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3035048C (en) | 2010-12-23 | 2021-05-04 | Mark Deem | System for mitral valve repair and replacement |
EP3964176A1 (en) | 2011-06-21 | 2022-03-09 | Twelve, Inc. | Prosthetic heart valve devices |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US10016271B2 (en) | 2011-10-19 | 2018-07-10 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
AU2012325809B2 (en) | 2011-10-19 | 2016-01-21 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US9283072B2 (en) | 2012-07-25 | 2016-03-15 | W. L. Gore & Associates, Inc. | Everting transcatheter valve and methods |
US9968443B2 (en) | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US10966820B2 (en) | 2012-12-19 | 2021-04-06 | W. L. Gore & Associates, Inc. | Geometric control of bending character in prosthetic heart valve leaflets |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US10039638B2 (en) | 2012-12-19 | 2018-08-07 | W. L. Gore & Associates, Inc. | Geometric prosthetic heart valves |
US10111747B2 (en) | 2013-05-20 | 2018-10-30 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
BR112016025723B1 (en) | 2014-05-06 | 2022-02-22 | Dsm Ip Assets B.V. | Prosthetic valve, set of leaflets and manufacturing method of said prosthetic valve |
AU2015305868B2 (en) | 2014-08-18 | 2018-09-20 | Edwards Lifesciences Corporation | Frame with integral sewing cuff for prosthetic valves |
US9827094B2 (en) | 2014-09-15 | 2017-11-28 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
CN107920895B (en) | 2015-08-21 | 2020-06-26 | 托尔福公司 | Implantable heart valve devices, mitral valve repair devices, and associated systems and methods |
EP3448316B1 (en) | 2016-04-29 | 2023-03-29 | Medtronic Vascular Inc. | Prosthetic heart valve devices with tethered anchors |
GB201616777D0 (en) | 2016-10-03 | 2016-11-16 | Univ Southampton | A frame for an implantable medical device and a method of manufacturing a frame for an implantable medical device |
RU2750619C1 (en) * | 2016-12-15 | 2021-06-30 | Мерил Лайф Сайенсиз Пвт Лтд | Artificial valve |
CN108261255B (en) * | 2016-12-30 | 2020-12-25 | 先健科技(深圳)有限公司 | Artificial heart valve device and valve leaf and support main body thereof |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
CA3071133C (en) | 2017-09-12 | 2023-02-28 | W.L. Gore & Associates, Inc. | Leaflet frame attachment for prosthetic valves |
JP7068444B2 (en) | 2017-09-27 | 2022-05-16 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | Artificial valves with expandable frames, as well as related systems and methods |
WO2019074607A1 (en) | 2017-10-13 | 2019-04-18 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve and delivery system |
AU2018362079B2 (en) | 2017-10-31 | 2021-09-16 | Edwards Lifesciences Corporation | Medical valve and leaflet promoting tissue ingrowth |
US11154397B2 (en) | 2017-10-31 | 2021-10-26 | W. L. Gore & Associates, Inc. | Jacket for surgical heart valve |
JP7227240B2 (en) | 2017-10-31 | 2023-02-21 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | artificial heart valve |
EP3703615B1 (en) | 2017-10-31 | 2024-05-15 | W. L. Gore & Associates, Inc. | Transcatheter deployment systems and associated methods |
USD926322S1 (en) | 2018-11-07 | 2021-07-27 | W. L. Gore & Associates, Inc. | Heart valve cover |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
US12004939B1 (en) | 2022-12-09 | 2024-06-11 | Renata Medical, Inc. | Transcatheter growth devices and methods for Norwood, Glenn and Fontan therapy |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6086612A (en) * | 1996-06-24 | 2000-07-11 | Adiam Medizintechnik Gmbh & Co. Kg | Mitral valve prosthesis |
US6171335B1 (en) * | 1997-01-24 | 2001-01-09 | Aortech Europe Limited | Heart valve prosthesis |
US20010007956A1 (en) * | 1996-12-31 | 2001-07-12 | Brice Letac | Valve prosthesis for implantation in body channels |
US20080200980A1 (en) * | 2006-10-19 | 2008-08-21 | Kevin Robin | Profile reduction of valve implant |
US20100145435A1 (en) * | 2008-02-21 | 2010-06-10 | Valerian Voinov | Implantable prosthetic valve stent |
US20120053676A1 (en) * | 2009-05-07 | 2012-03-01 | Ku David N | Implantable Prosthetic Vascular Valves |
US20120277856A1 (en) * | 2001-10-11 | 2012-11-01 | Edwards Lifesciences Pvt, Inc. | Implantable prosthetic valve |
US20140316516A1 (en) * | 2012-01-04 | 2014-10-23 | Tendyne Holdings, Inc. | Multi-component cuff designs for transcatheter mitral valve replacement subvalvular sealing apparatus for transcatheter mitral valves and wire framed leaflet assembly |
Family Cites Families (138)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3655306A (en) | 1970-01-19 | 1972-04-11 | Donald Nixon Ross | Apparatus for molding heart valves |
US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3744060A (en) | 1971-06-10 | 1973-07-10 | F Bellhouse | Prosthetic cardiac valve |
US4056854A (en) | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
NL8500538A (en) | 1985-02-26 | 1986-09-16 | Stichting Tech Wetenschapp | HEART VALVE PROSTHESIS, METHOD FOR MANUFACTURING A HEART VALVE PROSTHESIS AND MOLD USED THEREIN |
DE3541478A1 (en) | 1985-11-23 | 1987-05-27 | Beiersdorf Ag | HEART VALVE PROSTHESIS AND METHOD FOR THE PRODUCTION THEREOF |
DK124690D0 (en) | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5163955A (en) * | 1991-01-24 | 1992-11-17 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
CA2127701C (en) | 1992-01-27 | 1999-06-15 | John T. M. Wright | Annuloplasty and suture rings |
GB9206449D0 (en) | 1992-03-25 | 1992-05-06 | Univ Leeds | Artificial heart valve |
US5713950A (en) | 1993-11-01 | 1998-02-03 | Cox; James L. | Method of replacing heart valves using flexible tubes |
US5509930A (en) | 1993-12-17 | 1996-04-23 | Autogenics | Stentless heart valve |
US5562729A (en) | 1994-11-01 | 1996-10-08 | Biocontrol Technology, Inc. | Heart valve |
DE19546692C2 (en) | 1995-12-14 | 2002-11-07 | Hans-Reiner Figulla | Self-expanding heart valve prosthesis for implantation in the human body via a catheter system |
US5855601A (en) | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
DE19624948A1 (en) | 1996-06-24 | 1998-01-02 | Adiam Medizintechnik Gmbh & Co | Prosthetic heart valve |
US6764509B2 (en) | 1996-09-06 | 2004-07-20 | Carbomedics Inc. | Prosthetic heart valve with surface modification |
US6206911B1 (en) | 1996-12-19 | 2001-03-27 | Simcha Milo | Stent combination |
US5957949A (en) | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US5855597A (en) | 1997-05-07 | 1999-01-05 | Iowa-India Investments Co. Limited | Stent valve and stent graft for percutaneous surgery |
US7452371B2 (en) | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
US6117169A (en) | 1998-06-24 | 2000-09-12 | Sulzer Carbomedics Inc. | Living hinge attachment of leaflet to a valve body |
US6736845B2 (en) | 1999-01-26 | 2004-05-18 | Edwards Lifesciences Corporation | Holder for flexible heart valve |
US7628803B2 (en) | 2001-02-05 | 2009-12-08 | Cook Incorporated | Implantable vascular device |
US8382822B2 (en) | 1999-06-02 | 2013-02-26 | Cook Medical Technologies Llc | Implantable vascular device |
US6299637B1 (en) | 1999-08-20 | 2001-10-09 | Samuel M. Shaolian | Transluminally implantable venous valve |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US6458153B1 (en) | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US7195641B2 (en) | 1999-11-19 | 2007-03-27 | Advanced Bio Prosthetic Surfaces, Ltd. | Valvular prostheses having metal or pseudometallic construction and methods of manufacture |
GB0114345D0 (en) | 2001-06-13 | 2001-08-08 | Aortech Europ Ltd | Heart valve prosthesis and method of manufacture |
US20030097175A1 (en) | 1999-12-08 | 2003-05-22 | O'connor Bernard | Heart valve prosthesis and method of manufacture |
GB9928905D0 (en) * | 1999-12-08 | 2000-02-02 | Aortech Europ Ltd | Prosthesis |
PL199785B1 (en) | 2000-01-27 | 2008-10-31 | 3F Therapeutics | Prosthetic heart valve |
US6454799B1 (en) * | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US7510572B2 (en) | 2000-09-12 | 2009-03-31 | Shlomo Gabbay | Implantation system for delivery of a heart valve prosthesis |
US6482228B1 (en) | 2000-11-14 | 2002-11-19 | Troy R. Norred | Percutaneous aortic valve replacement |
US6953332B1 (en) | 2000-11-28 | 2005-10-11 | St. Jude Medical, Inc. | Mandrel for use in forming valved prostheses having polymer leaflets by dip coating |
US6596024B2 (en) | 2000-12-21 | 2003-07-22 | Carbomedics Inc. | Polymeric heart valve fabricated from polyurethane/polysiliconeurethane blends |
US6454798B1 (en) | 2000-12-21 | 2002-09-24 | Sulzer Carbomedics Inc. | Polymer heart valve with helical coaption surface |
US6916338B2 (en) | 2001-03-16 | 2005-07-12 | Mayo Foundation For Medical Education And Research | Synthetic leaflets for heart valve repair or replacement |
US7556646B2 (en) | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
US6958076B2 (en) | 2001-04-16 | 2005-10-25 | Biomedical Research Associates Inc. | Implantable venous valve |
US7377938B2 (en) | 2001-07-19 | 2008-05-27 | The Cleveland Clinic Foundation | Prosthetic cardiac value and method for making same |
US6562069B2 (en) | 2001-09-19 | 2003-05-13 | St. Jude Medical, Inc. | Polymer leaflet designs for medical devices |
US20030114924A1 (en) | 2001-12-18 | 2003-06-19 | Riyad Moe | Polymer heart valve |
US20060089708A1 (en) | 2002-02-20 | 2006-04-27 | Osse Francisco J | Venous bi-valve |
US6716241B2 (en) | 2002-03-05 | 2004-04-06 | John G. Wilder | Venous valve and graft combination |
US7125418B2 (en) | 2002-04-16 | 2006-10-24 | The International Heart Institute Of Montana Foundation | Sigmoid valve and method for its percutaneous implantation |
US7160320B2 (en) | 2002-04-16 | 2007-01-09 | The International Heart Institute Of Montana Foundation | Reed valve for implantation into mammalian blood vessels and heart with optional temporary or permanent support |
US8721713B2 (en) * | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
US7041132B2 (en) | 2002-08-16 | 2006-05-09 | 3F Therapeutics, Inc, | Percutaneously delivered heart valve and delivery means thereof |
GB2407146B (en) | 2003-03-20 | 2006-04-26 | Aortech Internat Plc | Valve leaflet for use in cardiac valve prosthesis |
EP2926772A1 (en) | 2003-04-24 | 2015-10-07 | Cook Medical Technologies LLC | Artificial valve prosthesis with improved flow dynamics |
US20050075729A1 (en) | 2003-10-06 | 2005-04-07 | Nguyen Tuoc Tan | Minimally invasive valve replacement system |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7261732B2 (en) | 2003-12-22 | 2007-08-28 | Henri Justino | Stent mounted valve |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
EP2526898B1 (en) | 2003-12-23 | 2013-04-17 | Sadra Medical, Inc. | Repositionable heart valve |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
CA2563426C (en) | 2004-05-05 | 2013-12-24 | Direct Flow Medical, Inc. | Unstented heart valve with formed in place support structure |
US20060122693A1 (en) * | 2004-05-10 | 2006-06-08 | Youssef Biadillah | Stent valve and method of manufacturing same |
WO2005118019A1 (en) | 2004-05-28 | 2005-12-15 | Cook Incorporated | Implantable bioabsorbable valve support frame |
US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
CA2593652A1 (en) | 2005-01-21 | 2006-08-17 | Innovia, Llc | Stent-valve and deployment catheter for use therewith |
ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
US20060200234A1 (en) * | 2005-03-03 | 2006-09-07 | Hines Richard A | Endovascular aneurysm treatment device and delivery system |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
WO2007016251A2 (en) | 2005-07-28 | 2007-02-08 | Cook Incorporated | Implantable thromboresistant valve |
US7455689B2 (en) | 2005-08-25 | 2008-11-25 | Edwards Lifesciences Corporation | Four-leaflet stented mitral heart valve |
US8470022B2 (en) | 2005-08-31 | 2013-06-25 | Cook Biotech Incorporated | Implantable valve |
US20070050013A1 (en) | 2005-09-01 | 2007-03-01 | Jeffrey M. Gross | Venous valve prosthesis and method of fabrication |
US7530253B2 (en) | 2005-09-09 | 2009-05-12 | Edwards Lifesciences Corporation | Prosthetic valve crimping device |
US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US20070078510A1 (en) | 2005-09-26 | 2007-04-05 | Ryan Timothy R | Prosthetic cardiac and venous valves |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US7648527B2 (en) | 2006-03-01 | 2010-01-19 | Cook Incorporated | Methods of reducing retrograde flow |
US8219229B2 (en) | 2006-03-02 | 2012-07-10 | Edwards Lifesciences Corporation | Virtual heart valve |
WO2007142935A1 (en) | 2006-05-30 | 2007-12-13 | Cook Incorporated | Artificial valve prosthesis |
EP2431061A3 (en) | 2006-06-09 | 2012-08-08 | Eidgenössische Technische Hochschule Zürich | Valve model for producing scaffolds for artificial heart valves and vascular structures |
EP2034929A4 (en) * | 2006-06-20 | 2010-04-07 | Aortx Inc | Prosthetic heart valves, support structures and systems and methods for implanting the same |
US8163011B2 (en) | 2006-10-06 | 2012-04-24 | BioStable Science & Engineering, Inc. | Intra-annular mounting frame for aortic valve repair |
WO2008046092A2 (en) * | 2006-10-13 | 2008-04-17 | Creighton University | Implantable valve prosthesis |
US9138315B2 (en) | 2007-04-13 | 2015-09-22 | Jenavalve Technology Gmbh | Medical device for treating a heart valve insufficiency or stenosis |
US8728154B2 (en) | 2007-08-24 | 2014-05-20 | St. Jude Medical, Inc. | Prosthetic aortic heart valves |
US20090062907A1 (en) | 2007-08-31 | 2009-03-05 | Quijano Rodolfo C | Self-expanding valve for the venous system |
US8454686B2 (en) | 2007-09-28 | 2013-06-04 | St. Jude Medical, Inc. | Two-stage collapsible/expandable prosthetic heart valves and anchoring systems |
US20090138079A1 (en) | 2007-10-10 | 2009-05-28 | Vector Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US20090171456A1 (en) * | 2007-12-28 | 2009-07-02 | Kveen Graig L | Percutaneous heart valve, system, and method |
EP2254513B1 (en) | 2008-01-24 | 2015-10-28 | Medtronic, Inc. | Stents for prosthetic heart valves |
DK2254514T3 (en) | 2008-01-24 | 2018-12-17 | Medtronic Inc | STENTS FOR HEART VALVE PROSTHESIS |
US8017396B2 (en) | 2008-02-22 | 2011-09-13 | Vijay Kumar | Cellulose based heart valve prosthesis |
US9241792B2 (en) | 2008-02-29 | 2016-01-26 | Edwards Lifesciences Corporation | Two-step heart valve implantation |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US9061119B2 (en) | 2008-05-09 | 2015-06-23 | Edwards Lifesciences Corporation | Low profile delivery system for transcatheter heart valve |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
US9061464B2 (en) * | 2008-09-03 | 2015-06-23 | Collagen Matrix, Inc. | Re-rollable wrapping implant |
US9314335B2 (en) | 2008-09-19 | 2016-04-19 | Edwards Lifesciences Corporation | Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US9119714B2 (en) | 2008-10-29 | 2015-09-01 | The Regents Of The University Of Colorado, A Body Corporate | Shape memory polymer prosthetic medical device |
US8556960B2 (en) | 2008-11-06 | 2013-10-15 | Cook Medical Technologies Llc | Frameless vascular valve |
BRPI1008902A2 (en) | 2009-02-27 | 2016-03-15 | St Jude Medical | prosthetic heart valve. |
US9980818B2 (en) | 2009-03-31 | 2018-05-29 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
EP2246011B1 (en) | 2009-04-27 | 2014-09-03 | Sorin Group Italia S.r.l. | Prosthetic vascular conduit |
US8075611B2 (en) | 2009-06-02 | 2011-12-13 | Medtronic, Inc. | Stented prosthetic heart valves |
WO2011072084A2 (en) * | 2009-12-08 | 2011-06-16 | Avalon Medical Ltd. | Device and system for transcatheter mitral valve replacement |
US9833314B2 (en) * | 2010-04-16 | 2017-12-05 | Abiomed, Inc. | Percutaneous valve deployment |
US10512537B2 (en) | 2010-04-16 | 2019-12-24 | Abiomed, Inc. | Flow optimized polymeric heart valve |
PT3590472T (en) | 2010-10-05 | 2021-04-14 | Edwards Lifesciences Corp | Prosthetic heart valve |
US8932343B2 (en) * | 2011-02-01 | 2015-01-13 | St. Jude Medical, Cardiology Division, Inc. | Blunt ended stent for prosthetic heart valve |
GB2488530A (en) * | 2011-02-18 | 2012-09-05 | David J Wheatley | Heart valve |
EP2734152A2 (en) | 2011-07-20 | 2014-05-28 | Boston Scientific Scimed, Inc. | Prosthetic heart valve |
US9603707B2 (en) | 2011-07-29 | 2017-03-28 | St. Jude Medical, Inc. | Dipping mandrel with a gap |
US9827093B2 (en) * | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9433991B2 (en) * | 2011-12-21 | 2016-09-06 | Edwards Lifesciences Corporation | Apparatus and method for stent shaping |
US9642700B2 (en) * | 2012-05-31 | 2017-05-09 | St. Jude Medical, Cardiology Division, Inc. | Prosthetic heart valve having a polymeric stent |
WO2014008207A1 (en) | 2012-07-02 | 2014-01-09 | Boston Scientific Scimed, Inc. | Prosthetic heart valve formation |
US10376360B2 (en) | 2012-07-27 | 2019-08-13 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic valve apparatus and methods |
US20140107772A1 (en) | 2012-10-12 | 2014-04-17 | St. Jude Medical, Cardiology Division, Inc. | Roughened cuff surface |
US9717592B2 (en) | 2012-10-29 | 2017-08-01 | Aneumed, Inc. | Personalized aortic valve prosthesis |
EP2986256B1 (en) * | 2013-04-19 | 2019-04-10 | Strait Access Technologies Holdings (Pty) Ltd | A prosthetic heart valve |
US9962259B2 (en) | 2013-06-25 | 2018-05-08 | National University Of Singapore | Stent member, artificial valve, and method of implanting the same |
WO2015042135A1 (en) | 2013-09-20 | 2015-03-26 | Edwards Lifesciences Corporation | Heart valves with increased effective orifice area |
WO2015081175A1 (en) | 2013-11-26 | 2015-06-04 | Children's Medical Center Corporation | Expandable stent valve |
CN106572906B (en) | 2014-05-06 | 2018-01-09 | 帝斯曼知识产权资产管理有限公司 | The method of manufacture of intraocular valve and the valve obtained using methods described |
EP3139865A4 (en) | 2014-05-07 | 2018-03-28 | Baylor College of Medicine | Artificial, flexible valves and methods of fabricating and serially expanding the same |
EP3142606B1 (en) | 2014-05-16 | 2020-04-29 | St. Jude Medical, Cardiology Division, Inc. | Subannular sealing for paravalvular leak protection |
US9827094B2 (en) | 2014-09-15 | 2017-11-28 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
EP4306080A3 (en) | 2014-12-09 | 2024-04-10 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and method of manufacture |
CN109414322B (en) * | 2017-04-07 | 2021-05-11 | 上海甲悦医疗器械有限公司 | Artificial valve |
WO2019081453A1 (en) * | 2017-10-23 | 2019-05-02 | Symetis Sa | Prosthetic valve leaflet |
US11202708B2 (en) * | 2017-11-08 | 2021-12-21 | The Charles Stark Draper Laboratory, Inc. | Segmented, growth-accommodating, artificial valve |
US11071626B2 (en) * | 2018-03-16 | 2021-07-27 | W. L. Gore & Associates, Inc. | Diametric expansion features for prosthetic valves |
US20210137676A1 (en) * | 2019-11-08 | 2021-05-13 | The Regents Of The University Of California | Growth-accommodating valve system |
-
2015
- 2015-05-06 EP EP15789240.7A patent/EP3139865A4/en active Pending
- 2015-05-06 WO PCT/US2015/029442 patent/WO2015171743A2/en active Application Filing
- 2015-05-06 US US15/308,667 patent/US20170189175A1/en not_active Abandoned
- 2015-05-06 CA CA2948179A patent/CA2948179C/en active Active
-
2019
- 2019-09-06 US US16/563,229 patent/US20200000581A1/en not_active Abandoned
-
2021
- 2021-09-13 US US17/473,653 patent/US11464632B2/en active Active
- 2021-09-17 US US17/478,665 patent/US11571300B2/en active Active
-
2022
- 2022-11-07 US US17/982,232 patent/US20230135271A1/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6086612A (en) * | 1996-06-24 | 2000-07-11 | Adiam Medizintechnik Gmbh & Co. Kg | Mitral valve prosthesis |
US20010007956A1 (en) * | 1996-12-31 | 2001-07-12 | Brice Letac | Valve prosthesis for implantation in body channels |
US20030109924A1 (en) * | 1996-12-31 | 2003-06-12 | Alain Cribier | Implanting a valve prosthesis in body channels |
US6171335B1 (en) * | 1997-01-24 | 2001-01-09 | Aortech Europe Limited | Heart valve prosthesis |
US20120277856A1 (en) * | 2001-10-11 | 2012-11-01 | Edwards Lifesciences Pvt, Inc. | Implantable prosthetic valve |
US20080200980A1 (en) * | 2006-10-19 | 2008-08-21 | Kevin Robin | Profile reduction of valve implant |
US20100145435A1 (en) * | 2008-02-21 | 2010-06-10 | Valerian Voinov | Implantable prosthetic valve stent |
US20120053676A1 (en) * | 2009-05-07 | 2012-03-01 | Ku David N | Implantable Prosthetic Vascular Valves |
US20140316516A1 (en) * | 2012-01-04 | 2014-10-23 | Tendyne Holdings, Inc. | Multi-component cuff designs for transcatheter mitral valve replacement subvalvular sealing apparatus for transcatheter mitral valves and wire framed leaflet assembly |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11464632B2 (en) * | 2014-05-07 | 2022-10-11 | Baylor College Of Medicine | Transcatheter and serially-expandable artificial heart valve |
US11571300B2 (en) * | 2014-05-07 | 2023-02-07 | Baylor College Of Medicine | Serially expanding an artificial heart valve within a pediatric patient |
US11617644B2 (en) | 2014-10-13 | 2023-04-04 | W. L. Gore & Associates, Inc. | Prosthetic valved conduit |
US11351058B2 (en) | 2017-03-17 | 2022-06-07 | W. L. Gore & Associates, Inc. | Glaucoma treatment systems and methods |
US11523940B2 (en) | 2017-03-17 | 2022-12-13 | W. L. Gore & Associates, Inc. | Delivery aids for glaucoma shunts |
US11406533B2 (en) | 2017-03-17 | 2022-08-09 | W. L. Gore & Associates, Inc. | Integrated aqueous shunt for glaucoma treatment |
US11986387B2 (en) * | 2017-09-27 | 2024-05-21 | Edwards Lifesciences Corporation | Prosthetic valves with mechanically coupled leaflets |
US20210338422A1 (en) * | 2017-09-27 | 2021-11-04 | W. L. Gore & Associates, Inc. | Prosthetic valves with mechanically coupled leaflets |
US11039919B2 (en) | 2017-10-31 | 2021-06-22 | W. L. Gore & Associates, Inc. | Valved conduit |
US12004948B2 (en) * | 2017-11-16 | 2024-06-11 | Children's Medical Center Corporation | Geometrically-accommodating heart valve replacement device |
US20200360135A1 (en) * | 2017-11-16 | 2020-11-19 | Children's Medical Center Corporation | Geometrically-accommodating heart valve replacement device |
CN111818876A (en) * | 2017-11-16 | 2020-10-23 | 儿童医学中心公司 | Geometrically adaptive heart valve replacement device |
US11000369B2 (en) * | 2017-12-11 | 2021-05-11 | California Institute Of Technolgy | Systems, devices, and methods relating to the manufacture of intravascularly implantable prosthetic valves |
CN111801070A (en) * | 2017-12-11 | 2020-10-20 | 加州理工学院 | Systems, devices, and methods related to the manufacture of endovascular implantable prosthetic valves |
US20190343625A1 (en) * | 2017-12-11 | 2019-11-14 | Foldax, Inc. | Systems, devices, and methods relating to the manufacture of intravascularly implantable prosthetic valves |
US11478352B2 (en) * | 2018-04-09 | 2022-10-25 | Hangzhou Nuoyi Medtech Co., Ltd | Venous valve replacement device |
CN110353858A (en) * | 2018-04-09 | 2019-10-22 | 倍芮医疗器械(上海)有限公司 | For loading the bracket and venous valve displacement apparatus of valve |
USD977642S1 (en) | 2018-10-29 | 2023-02-07 | W. L. Gore & Associates, Inc. | Pulmonary valve conduit |
US11678983B2 (en) | 2018-12-12 | 2023-06-20 | W. L. Gore & Associates, Inc. | Implantable component with socket |
US11547557B2 (en) | 2018-12-13 | 2023-01-10 | Abbott Laboratories | Stabilized fabric material for medical devices |
US12076234B2 (en) | 2018-12-13 | 2024-09-03 | Abbott Laboratories | Stabilized fabric material for medical devices |
WO2020191386A1 (en) * | 2019-03-21 | 2020-09-24 | The Trustees Of Columbia University In The City Of New York | Transcatheter dilatable biostable polymeric stented valved tube prosthesis |
WO2022066961A1 (en) * | 2020-09-23 | 2022-03-31 | ReValve Solutions Inc. | Devices, systems, and methods for an implantable heart-valve adapter |
WO2023060330A1 (en) * | 2021-10-15 | 2023-04-20 | Angel Maluf Miguel | Polyurethane-coated, expandable stented valve prosthesis designed with anatomic cusps for implanting by catheter in the pulmonary position in pediatric and adult patients, and method for producing expandable stented valve prosthesis |
WO2023095033A1 (en) * | 2021-11-23 | 2023-06-01 | Medtronic, Inc. | Leaflet design for a heart valve prosthesis |
US11969342B2 (en) | 2022-08-03 | 2024-04-30 | The Children's Medical Center Corporation | Geometrically-accommodating heart valve replacement device |
Also Published As
Publication number | Publication date |
---|---|
US20220125581A1 (en) | 2022-04-28 |
US20230135271A1 (en) | 2023-05-04 |
US20200000581A1 (en) | 2020-01-02 |
WO2015171743A3 (en) | 2015-12-17 |
US11571300B2 (en) | 2023-02-07 |
EP3139865A4 (en) | 2018-03-28 |
US20220117731A1 (en) | 2022-04-21 |
EP3139865A2 (en) | 2017-03-15 |
CA2948179C (en) | 2023-08-15 |
CA2948179A1 (en) | 2015-11-12 |
US11464632B2 (en) | 2022-10-11 |
WO2015171743A2 (en) | 2015-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11464632B2 (en) | Transcatheter and serially-expandable artificial heart valve | |
JP7393005B2 (en) | Replacement heart valve with fewer sutures | |
US10881507B2 (en) | Prosthetic valves, frames and leaflets and methods thereof | |
US10864094B2 (en) | Fatigue-resistant flow regulating device and manufacturing methods | |
EP2379322B1 (en) | Synthetic composite structures | |
US9827089B2 (en) | Methods for improved prosthetic heart valve with leaflet shelving | |
JP6503454B2 (en) | Replacement heart valves and methods of their use and manufacture | |
KR102138396B1 (en) | Geometric control of bending character in prosthetic heart valve leaflets | |
EP2934389B1 (en) | Multi-frame prosthetic heart valve | |
US9456898B2 (en) | Heart valve prosthesis with open stent | |
US7566343B2 (en) | Cardiac valve, system, and method | |
US20170020672A1 (en) | Venous valve, system, and method with sinus pocket | |
EP1237509B1 (en) | Implantable prosthetic valve | |
US20180168795A1 (en) | Valved conduit and method for fabricating same | |
WO2013160651A1 (en) | Valve | |
EP3644905B1 (en) | Tri-leaflet prosthetic heart valve |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCV | Information on status: appeal procedure |
Free format text: NOTICE OF APPEAL FILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |